This study asks whether shingles vaccination matters only for preve...
Natural experiments are situations where real-world events, policie...
Because neuroinflammation is thought to be central to how dementia ...
> "To guide further research in this area and, ultimately, inform a...
This is a very interesting resullt: > "The effect of HZ vaccin...
> In conclusion, this study suggests that HZ vaccination slows or p...
Article
The effect of shingles vaccination at different stages
of the dementia disease course
Graphical abstract
Highlights
Herpes zoster vaccination reduced dementia diagnosis in
our prior natural experiments
Here, we find a lower occurrence of MCI and dementia
deaths among dementia patients
Herpes zoster vaccination appears to act along the entire
clinical course of dementia
This study’s approach avoids the common confounding
concerns of observational data
Authors
Min Xie, Markus Eyting,
Christian Bommer, Haroon Ahmed,
Pascal Geldsetzer
Correspondence
pgeldsetzer@stanford.edu
In brief
A natural experiment found that herpes
zoster vaccination reduced the
occurrence of mild cognitive impairment
and deaths due to dementia, indicating
that the vaccine may slow the
progression of dementia throughout its
clinical disease course.
Xie et al., 2025, Cell 188, 1–16
December 11, 2025 © 2025 The Author(s). Published by Elsevier Inc.
https://doi.org/10.1016/j.cell.2025.11.007
ll
Article
The effect of shingles vaccination at different
stages of the dementia disease course
Min Xie,
1,2
Markus Eyting,
2,3,4
Christian Bommer,
2
Haroon Ahmed,
5
and Pascal Geldsetzer
2,6,7,8,9,
*
1
Heidelberg Institute of Global Health, Heidelberg University Hospital, 69120 Heidelberg, Germany
2
Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, CA 94305, USA
3
Faculty of Law and Economics, Johannes Gutenberg University Mainz, 55122 Mainz, Germany
4
Leibniz Institute for Financial Research SAFE, 60323 Frankfurt am Main, Germany
5
Division of Population Medicine, School of Medicine, Cardiff University, Cardiff CF14 4YS, UK
6
The Phil and Penny Knight Initiative for Brain Resilience at the Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA 94305, USA
7
Stanford Center for Digital Health, Stanford University, Stanford, CA 94305, USA
8
Biohub, San Francisco, CA 94158, USA
9
Lead contact
*Correspondence: pgeldsetzer@stanford.edu
https://doi.org/10.1016/j.cell.2025.11.007
SUMMARY
Using natural experiments, we have previously reported that live-attenuated herpes zoster (HZ) vaccination
appears to have prevented or delayed dementia diagnoses in both Wales and Australia. Here, we find that HZ
vaccination also reduces mild cognitive impairment diagnoses and, among patients living with dementia,
deaths due to dementia. Exploratory analyses suggest that the effects are not driven by a specific dementia
type. Our approach takes advantage of the fact that individuals who had their eightieth birthday just after the
start date of the HZ vaccination program in Wales were eligible for the vaccine for 1 year, whereas those who
had their eightieth birthday just before were ineligible and remained ineligible for life. The key strength of our
natural experiments is that these comparison groups should be similar in all characteristics except for a min-
ute difference in age. Our findings suggest that live-attenuated HZ vaccination prevents or delays mild cogni-
tive impairment and dementia and slows the disease course among those already living with dementia.
INTRODUCTION
Given the key role of neuroinflammation in the development and
progression of dementia,
1
it is conceivable that neurotropic vi-
ruses could be a factor that causes or accelerates the dementia
disease process. Neurotropic herpesviruses have thus far
received the greatest research attention in this regard,
2–4
partly
because they remain latent for life in the nervous system after pri-
mary infection, are more likely to reactivate with increasing age,
and can cause encephalitis.
5
Recently, several findings have
further spurred interest in neurotropic herpesviruses, including
the observation that they can seed β-amyloid in mice
6
and in-
crease tau phosphorylation in human brain organoids
7
and that
the Epstein-Barr virus appears to be a causative factor in the
development of multiple sclerosis.
8
Clinical and subclinical reactivations of the neurotropic
herpesvirus (the varicella zoster virus) that causes chickenpox
and shingles may constitute a chronic immune stressor that
drives inflammatory pathways in both the peripheral and central
nervous system, interfering with neuroimmune homeostasis in
older age.
9
The varicella zoster virus has also recently been
linked to amyloid deposition and aggregation of tau proteins,
10
as well as cerebrovascular disease that resembles the patterns
commonly seen in Alzheimer’s disease, such as small- to
large-vessel disease, ischemia, infarction, and hemorrhage.
11–16
Reducing clinical and subclinical reactivations of the virus
through herpes zoster (HZ) vaccination might thus have a bene-
ficial impact on the development or progression of dementia, as
well as neuroimmune health and cognitive reserve in older age
more broadly. Moreover, as has been detailed recently else-
where,
17
it is possible that HZ vaccination, and potentially vacci-
nations in older age more generally, act on the dementia disease
process through a pathogen-independent immune mechanism.
Such an effect might counteract immunosenescence
17,18
and
would add to the growing body of evidence suggesting that vac-
cines frequently have broader health benefits beyond their in-
tended target.
19–22
Of importance with respect to this present
study, these beneficial off-target effects have often been found
to be far stronger among female than male individuals,
20
as
well as for live-attenuated rather than other types of
vaccines.
19–21,23
In a recent study,
24
we were able to take advantage of a unique
quasi-randomization in Wales to provide evidence of the effect of
HZ vaccination on new dementia diagnoses that is more likely to
be causal than the previously existing associational evidence.
This opportunity arose because the UK National Health Service
ll
OPEN ACCESS
Cell 188, 1–16, December 11, 2025 © 2025 The Author(s). Published by Elsevier Inc. 1
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
rolled out the live-attenuated HZ vaccine (Zostavax, Merck) us-
ing strict date-of-birth-based eligibility rules.
25
These rules re-
sulted in an increase in the probability of ever receiving the HZ
vaccine of almost 50 percentage points between individuals
who differed in age by merely a week across the date-of-birth-
based eligibility threshold for the vaccination program. We thus
had the opportunity to compare dementia incidence between
eligible and ineligible groups of individuals who were not ex-
pected to differ in their characteristics other than a difference
in age of merely a few weeks and a large difference in ever having
received the HZ vaccine. We found that HZ vaccination averted
an estimated one in five new dementia diagnoses over a 7-year
follow-up period. Crucially, unlike the previously existing associ-
ational evidence,
26–35
this study is not subject to the fundamental
concern in associational studies that those who opt to be vacci-
nated differ from those who do not in a variety of characteristics
that are difficult to measure.
36
Most recently, taking advantage of
a similar date-of-birth-based rollout of HZ vaccination in
Australia, we have shown that this protective effect for new diag-
noses of dementia from live-attenuated HZ vaccination also ap-
pears to exist in the Australian population.
37
To guide further research in this area and, ultimately, inform
appropriate clinical care, it is critical to understand at which
stage of the disease course of dementia HZ vaccination has its
benefit. Our previous analyses in Wales and Australia have left
this question unanswered. The aims of this study, therefore,
were 2-fold: to determine the effect of HZ vaccination on (1)
new diagnoses of mild cognitive impairment (MCI) among indi-
viduals without any record of cognitive impairment and (2)
deaths due to dementia among individuals living with dementia.
In the absence of more widespread testing for β-amyloid and tau
pathology during the study period (2013–2022), these two aims
represent the two opposite ends of the disease course of de-
mentia (considering the limitations in ascertaining different dis-
ease stages in electronic health record data). Here, we report a
large beneficial effect from live-attenuated HZ vaccination for
both aims, suggesting that the vaccine appears to act across
the entire clinical disease course of dementia.
RESULTS
Sample characteristics
We used the Secure Anonymised Information Linkage (SAIL) da-
tabank.
38
Our dataset, which consisted of electronic health re-
cord data from approximately 80% of Wales’s primary care
practices,
39
was linked by SAIL to hospital-based care data as
well as death certificate data (Table 1). Our dataset consisted
of 304,940 individuals born between September 1, 1925, and
September 1, 1942, who were alive and residing in Wales as of
September 1, 2013. Of these individuals, 282,557 did not have
a record of any cognitive impairment prior to September 1,
2013, and were thus included in our study cohort for analyzing
the effect of HZ vaccination on MCI. Our study cohort for
analyzing the effect of HZ vaccination on deaths due to dementia
consisted of the 14,350 individuals in our dataset who had
received a diagnosis of dementia prior to September 1, 2013.
The sample characteristics of each of these two cohorts are
shown in Table 2.
A 1-week difference in age led to a large difference in HZ
vaccination uptake
We analyzed our data using a regression discontinuity design,
which is a well-established causal effect estimation technique
that is guided by the expectation that individuals born just on
either side of the date-of-birth eligibility threshold for HZ vacci-
nation likely are similar to each other except for their probability
of receiving the HZ vaccine.
41–43
In both of our study cohorts, a
1-week difference in age across the September 2, 1933, date-of-
birth eligibility threshold resulted in a large difference in the
probability of ever receiving the HZ vaccination (Figures 1 and
S10). Specifically, among individuals without any record of
cognitive impairment prior to the start of the HZ vaccination pro-
gram, being born 1 week after September 2, 1933, and thus be-
ing eligible for HZ vaccination, led to an abrupt increase in the
probability of ever receiving the HZ vaccination from 0.0% to
45.9% (p < 0.001). The corresponding abrupt increase among
patients living with dementia on the start date of the HZ vaccina-
tion program was from 0.0% to 28.7% (p < 0.001). Thus, as ex-
pected, in both of our study cohorts, the eligibility rules of the HZ
vaccination program created comparison groups born just on
either side of the September 2, 1933, date-of-birth threshold
who (after flexibly controlling for age) were likely similar to each
other except for a large difference in the probability of receiving
the HZ vaccination.
Prior to the start date of the HZ vaccination program, there
were no significant differences at the September 2, 1933, date-
of-birth threshold in the uptake of preventive health services,
the prevalence of any of the ten most common causes of
disability-adjusted life years (DALYs) and mortality among adults
aged 70+ years in Wales (except ischemic heart disease among
those living with dementia at program start),
44
or in the occur-
rence of HZ, diagnoses of MCI, and deaths due to dementia
(Figure S1).
A protective effect of HZ vaccination on new diagnoses
of MCI
To determine the effect of being eligible for HZ vaccination on our
outcomes, our analytical strategy focused on comparing individ-
uals who were not eligible for the HZ vaccine because they
turned 80 years of age immediately before the program’s start
date with those who were eligible because they turned 80 years
of age immediately after the start date. Following standard
regression discontinuity methods,
41,42
we estimated the effect
of actually receiving the vaccine (rather than merely being
eligible) using a two-stage least-squares regression. This
approach divides the size of the sudden change in the outcome
at the date-of-birth eligibility cutoff by the size of the sudden
change in vaccine uptake at that same cutoff. As a result, the
fact that not everyone who was eligible actually received the vac-
cine does not introduce bias into our analysis.
Among our study cohort of individuals without any record of
cognitive impairment prior to the start date of the HZ vaccination
program, 20,712 (7.3%) were newly diagnosed with MCI during
our 9-year follow-up period. Being born immediately after versus
immediately before September 2, 1933, and thus being eligible
for HZ vaccination, decreased the occurrence of new diagnoses
of MCI over 9 years by 1.5 (95% confidence interval [CI]: 0.5–2.9,
ll
OPEN ACCESS
2 Cell 188, 1–16, December 11, 2025
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
p = 0.006) percentage points (Figure 2). Scaled to the proportion
of individuals who took up HZ vaccination if they were eligible us-
ing our regression discontinuity approach, the effect of actually
receiving the HZ vaccination was a 3.1 (95% CI: 1.0–6.2, p =
0.007) percentage point reduction in new diagnoses of MCI
over 9 years. The effect across different follow-up periods is
shown in Figure S2. Both the effect of being eligible for HZ vacci-
nation and the effect of actually receiving the HZ vaccination
were robust across different choices of bandwidth, grace period,
and functional form (using local quadratic instead of local linear
regression), when requiring that a new MCI diagnosis not be fol-
lowed by a new dementia diagnosis within 0–3 months or within
0–6 months, when adjusting for the staggered rollout of the pro-
gram, when adjusting for indicators of health service utilization,
and when restricting the analysis cohort to frequent primary
care visitors (Figure S3).
A protective effect of HZ vaccination on deaths due to
dementia
Among our study cohort of individuals with a diagnosis of
dementia received prior to the start date of the HZ vaccination
program, 7,049 (49.1%) died due to dementia (i.e., had dementia
recorded as the underlying cause of death in their death certifi-
cate) over the 9-year follow-up period. Being eligible for HZ
vaccination (i.e., being born shortly after versus shortly before
September 2, 1933) decreased the occurrence of deaths due
Table 1. Characteristics of each dataset used in this study
Dataset Description
Welsh Demographic Service Dataset
(WDSD)
87
This is a registry of all individuals registered with a primary care provider in Wales (over 98% of
adults residing in Wales are registered with a primary care provider
92
). The following variables
from this dataset were used in this study: date of birth in weeks, sex, individuals’ anonymized
address history (to define residence status in Wales), and the 2011 Welsh Index of Multiple
Deprivation (the government’s measure of relative deprivation for small areas in Wales
40
) for
each address history. Data were available until March 2023.
Welsh Longitudinal General Practice
dataset (WLGP)
39
This dataset contains comprehensive electronic health record data from primary care for
approximately 80% of primary care practices in Wales and 83% of the Welsh population. Our
study population was extracted from this dataset. All health events are encoded with Read
codes
86
and include diagnoses, clinical signs and observations, symptoms, medication
prescriptions, laboratory tests and results, procedures performed (including vaccinations), and
administrative items. This dataset formed the core of our analysis. All variables listed in Data S1
that include Read codes in their definition were at least partially ascertained using this dataset:
these variables include those needed to ascertain our study cohorts, primary and secondary
outcomes, HZ vaccination, diagnoses for our baseline balance checks and negative control
outcome analyses, uptake of preventive health services other than HZ vaccination, and
healthcare service utilization indicators. Data were available until January 2023.
Patient Episode Database for Wales
(PEDW)
88
This dataset contains electronic health record data for all inpatient and day case activity
undertaken in hospitals of NHS Wales as well as data on Welsh residents treated in hospitals
that are part of NHS England. Procedures are encoded using OPCS-4 codes
93
and diagnoses
using ICD-10 codes.
94
From this dataset, we used dates of admission (to identify the timing of a
specific diagnosis and ascertain our healthcare service utilization indicators) and diagnosis
codes (to identify a condition first diagnosed in the hospital setting) in this study. The data
covered the period from April 1995 to March 2023.
Outpatient Database for Wales (OPDW)
89
This dataset contains attendance information for all hospital-based outpatient appointments.
We used dates of attendances from this dataset to ascertain our healthcare service utilization
indicators. Patients in the NHS generally have to obtain a referral from a primary care provider to
access outpatient specialist care
84
; thus, referrals to, and diagnoses made in, specialist care
are contained in the Welsh Longitudinal General Practice dataset. The data covered the period
from January 2004 to March 2023.
Welsh Cancer Intelligence and Surveillance
Unit (WCISU)
92
This is the national cancer registry for Wales, which records all cancer diagnoses given to Welsh
residents regardless of the setting in which they were diagnosed or treated. We used dates of
diagnoses (to identify the timing of a specific cancer diagnosis) and diagnosis codes (to identify
a specific cancer) from this dataset. The data covered the period from January 1994 to July
2022.
Annual District Death Extract (ADDE)
91
This is the national registry of all deaths of Welsh residents, including deaths of Welsh residents
that occurred outside of Wales. Cause-of-death data from death certificates used ICD-9 coding
until 2001 and ICD-10 coding thereafter. Dates for deaths were those on which the death was
registered, as opposed to when it occurred. The median delay between death occurrence and
registration in England and Wales in the years from 2001 to 2021 was 5 days.
95
We used date of
death (to identify the timing of death) as well as cause of death (both underlying and contributing
causes) in this study. More detailed information on mortality statistics in the United Kingdom is
available elsewhere.
96
The data covered the period from October 1973 to March 2023.
ll
OPEN ACCESS
Cell 188, 1–16, December 11, 2025 3
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
Table 2. Sample characteristics at baseline of the two study cohorts in our analysis
Among patients without cognitive impairment at baseline
a,b,c,d,e
Variable
Full sample Sample in the MSE-optimal bandwidth
All Women Men All Women Men
n % n % n % n % n % n %
282,557 100.0 154,238 54.6 128,318 45.4 58,569 100.0 32,311 55.2 26,258 44.8
Quintile of
Welsh Index
of Multiple
Deprivation
1 (most deprived) 47,321 16.7 26,071 16.9 21,249 16.6 9,654 16.5 5,391 16.7 4,263 16.2
2 53,628 19.0 29,517 19.1 24,111 18.8 11,060 18.9 6,248 19.3 4,812 18.3
3 61,528 21.8 33,596 21.8 27,932 21.8 12,854 21.9 7,081 21.9 5,773 22.0
4 58,352 20.7 31,461 20.4 26,891 21.0 12,117 20.7 6,569 20.3 5,548 21.1
5 (least deprived) 61,728 21.8 33,593 21.8 28,135 21.9 12,884 22.0 7,022 21.7 5,862 22.3
Clinical
diagnoses
past shingles 34,280 12.1 20,461 13.3 13,819 10.8 7,611 13.0 4,592 14.2 3,019 11.5
ischemic heart disease 45,456 16.1 17,928 11.6 27,528 21.5 10,488 17.9 4,168 12.9 6,320 24.1
COPD 33,191 11.7 15,586 10.1 17,605 13.7 7,164 12.2 3,314 10.3 3,850 14.7
past stroke 20,938 7.4 10,028 6.5 10,910 8.5 4,879 8.3 2,362 7.3 2,517 9.6
past lower respiratory
tract infection
145,299 51.4 80,215 52.0 65,084 50.7 30,880 52.7 16,980 52.6 13,900 52.9
history of lung cancer 1,179 0.4 554 0.4 625 0.5 268 0.5 130 0.4 138 0.5
past fall(s) 52,620 18.6 35,998 23.3 16,622 13.0 11,897 20.3 8,161 25.3 3,736 14.2
history of colorectal cancer 5,662 2.0 2,445 1.6 3,217 2.5 1,295 2.2 557 1.7 738 2.8
history of lower back pain 126,210 44.7 72,251 46.8 53,959 42.1 26,471 45.2 15,379 47.6 11,092 42.2
history of breast cancer 6,450 4.2 1,319 4.1
history of pancreatic cancer 162 <0.1 81 <0.1 81 <0.1 28 <0.1 14 <0.1 14 <0.1
diabetes mellitus 55,354 19.6 26,289 17.0 29,065 22.7 12,185 20.8 5,903 18.3 6,282 23.9
Uptake of
preventive
health
measures
breast cancer screening 34,680 22.5 5,952 18.4
PPV-23 198,677 70.3 106,803 69.2 91,874 71.6 42,872 73.2 23,109 71.5 19,763 75.3
influenza vaccine 193,856 68.6 103,677 67.2 90,178 70.3 41,411 70.7 22,247 68.9 19,164 73.0
recent statin use 130,175 46.1 65,910 42.7 64,265 50.1 27,747 47.4 14,449 44.7 13,298 50.6
recent antihypertensive use 172,148 60.9 93,026 60.3 79,122 61.7 37,711 64.4 20,651 63.9 17,060 65.0
Among patients living with dementia at baseline
a,b,c,d,e
Variable
Full sample Sample in the MSE-optimal bandwidth
All Women Men All Women Men
n % n % n % n % n % n %
14,350 100.0 8,957 62.4 5,393 37.6 3,418 100.0 2,064 60.4 1,354 39.6
Quintile of
Welsh Index
of Multiple
Deprivation
1 (most deprived) 2,734 19.1 1,699 19.0 1,035 19.2 648 19.0 408 19.8 240 17.7
2 3,012 21.0 1,897 21.2 1,115 20.7 729 21.3 458 22.2 271 20.0
3 3,021 21.1 1,932 21.6 1,089 20.2 730 21.4 440 21.3 290 21.4
4 2,788 19.4 1,718 19.2 1,070 19.8 655 19.2 379 18.4 276 20.4
5 (least deprived) 2,795 19.5 1,711 19.1 1,084 20.1 656 19.2 379 18.4 277 20.5
Clinical
diagnoses
past shingles 1,761 12.3 1,176 13.1 585 10.8 400 11.7 254 12.3 146 10.8
ischemic heart disease 2,975 20.7 1,513 16.9 1,462 27.1 725 21.2 360 17.4 365 27.0
COPD 2,073 14.4 1,133 12.6 940 17.4 475 13.9 253 12.3 222 16.4
past stroke 2,654 18.5 1,461 16.3 1,193 22.1 640 18.7 325 15.7 315 23.3
past lower respiratory
tract infection
8,661 60.4 5,365 59.9 3,296 61.1 2,013 58.9 1,196 57.9 817 60.3
history of lung cancer 58 0.4 28 0.3 30 0.6 20 0.6 10 0.5 10 0.7
past fall(s) 6,652 46.4 4,608 51.4 2,044 37.9 1,476 43.2 983 47.6 493 36.4
history of colorectal cancer 285 2.0 138 1.5 147 2.7 60 1.8 25 1.2 35 2.6
history of lower back pain 6,530 45.5 4,161 46.5 2,369 43.9 1,573 46.0 996 48.3 577 42.6
history of breast cancer 298 3.3 68 3.3
history of pancreatic cancer <10 <0.1 <10 <0.1 <10 <0.1 <10 <0.1 <10 <0.1 <10 <0.1
diabetes mellitus 3,332 23.2 1,926 21.5 1,406 26.1 853 25.0 486 23.5 367 27.1
(Continued on next page)
ll
OPEN ACCESS
4 Cell 188, 1–16, December 11, 2025
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
to dementia over 9 years by 8.5 (95% CI: 0.6–18.5, p = 0.036)
percentage points (Figure 2). The effect of actually receiving
the HZ vaccination was a 29.5 (95% CI: 0.6–62.9, p = 0.046) per-
centage point reduction in deaths due to dementia over 9 years.
Our difference-in-differences analysis (detailed in the STAR
Methods and Figure S11) yielded similar results as our regres-
sion discontinuity analysis (Figure 2). The effect across different
follow-up periods is shown in Figure S2. As for MCI as outcome,
the point estimates for the effect of being eligible for HZ vaccina-
tion and the effect of actually receiving the HZ vaccination were
robust across different choices of bandwidth, grace period, and
functional form (using local quadratic instead of local linear
regression) and when adjusting for the staggered rollout of the
program (Figure S3). In addition, the effect remained significant
when adjusting for the baseline imbalance in ischemic heart dis-
eases diagnoses using a fully non-parametric regression discon-
tinuity method that can flexibly control for such baseline imbal-
ances (Figure S3).
45
Evidence against the existence of confounding
Given the focus of our regression discontinuity approach on
changes in the outcome variable at the date-of-birth eligibility
threshold, a confounding variable would only bias our analysis
if it changed abruptly at the September 2, 1933, date-of-birth
threshold. Such bias could arise if another intervention used
the identical date-of-birth eligibility threshold (i.e., September
2, 1933) as the HZ vaccination program. As detailed in the
STAR Methods, we tested for this possibility in four ways.
First, the September 2 date-of-birth eligibility threshold only
had a significant effect on our outcomes in the birth year
(1933) that was used by the HZ vaccination program but not
in any of the 3 birth years prior to and after 1933 (Figure S4).
This finding reduces the probability that an annual intervention
existed that also used September 2 as a date-of-birth eligibility
criterion.
Second, at the time of the start date of the HZ vaccination pro-
gram, we did not observe systematic differences across the
September 2, 1933, date-of-birth threshold in past preventive
health services uptake nor the prevalence of the ten leading
causes of DALYs and mortality among adults aged 70+ years in
Wales (Figure S1). Third, there were no significant differences in
the incidence of new MCI diagnoses (in our study cohort for
analyzing the effect on MCI) and deaths due to dementia (in our
study cohort for analyzing the effect on deaths due to dementia)
across the September 2, 1933, date-of-birth threshold in the 9
years before the start of the HZ vaccination program (MCI: 0.0
[95% CI: 0.5 to 0.6, p = 0.953] percentage points; deaths due
to dementia: 5.2 [ 17.7 to 6.7, p = 0.375] percentage points).
Together, these tests reduce the likelihood that a competing inter-
vention (i.e., another intervention that used the identical date-of-
birth eligibility threshold as the HZ vaccination program) existed
that was implemented prior to the HZ vaccination program.
Fourth, other than for dementia, we did not observe any sig-
nificant effects of the September 2, 1933, date-of-birth eligi-
bility threshold on diagnoses of each of the ten most common
causes of DALYs and mortality (in our study cohort for
analyzing the effect on MCI) and deaths due to the ten leading
causes of mortality (in our study cohort for analyzing the effect
on deaths due to dementia) among adults aged 70+ years in
Wales over our 9-year follow-up period (Figure 3). Neither did
we observe any effects on indicators of preventive health ser-
vices uptake during our follow-up period (Figure 3). These tests
provide evidence against the existence of an intervention that
used the identical date-of-birth eligibility threshold as the HZ
vaccination program and was not specifically designed to
only affect our primary outcomes.
Table 2. Continued
Among patients living with dementia at baseline
a,b,c,d,e
Variable
Full sample Sample in the MSE-optimal bandwidth
All Women Men All Women Men
n % n % n % n % n % n %
Uptake of
preventive
health
measures
breast cancer screening 1,327 14.8 323 15.6
PPV-23 10,478 73.0 6,330 70.7 4,148 76.9 2,512 73.5 1,473 71.4 1,039 76.7
influenza vaccine 9,586 66.8 5,840 65.2 3,746 69.5 2,263 66.2 1,331 64.5 932 68.8
recent statin use 6,596 46.0 3,863 43.1 2,733 50.7 1,650 48.3 938 45.4 712 52.6
recent antihypertensive use 7,535 52.5 4,608 51.4 2,927 54.3 1,801 52.7 1,058 51.3 743 54.9
Abbreviations are as follows: Sept, September; MSE, mean squared error; COPD, chronic obstructive pulmonary disease; PPV-23, pneumococcal
polysaccharide vaccine.
a
The baseline date was September 1, 2013 (the start date of the HZ vaccination program).
b
The length of the MSE-optimal bandwidth (used in our complier average causal effect analysis) was 95.1 weeks for patients without cognitive impair-
ment at baseline and 97.5 weeks for patients living with dementia at baseline.
c
Deciles of the Welsh Index of Multiple Deprivation (WIMD) were calculated based on the 2011 WIMD survey.
40
d
Breast cancer screening was defined as the proportion of women with a record of referral to, attendance at, or a report from ‘breast cancer screening’’
or mammography at any time prior to September 1, 2013. ‘PPV-23’ was defined as receipt of the pneumococcal vaccine as an adult at any time prior
to September 1, 2013. ‘Influenza vaccine’ was defined as influenza vaccine receipt in the 12 months preceding September 1, 2013. Recent statin and
antihypertensive use was defined as a new or repeat prescription of a statin or antihypertensive drug, respectively, in the 12 months preceding
September 1, 2013.
e
Diabetes mellitus referred to both diabetes mellitus type 1 and type 2.
ll
OPEN ACCESS
Cell 188, 1–16, December 11, 2025 5
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
The protective effects were larger among women than
men
The effect of HZ vaccination—both on reducing new diagnoses
of MCI and deaths due to dementia—was larger among women
than men (Figure 4). Among women, the effects of being eligible
for, and actually receiving, HZ vaccination on new diagnoses of
MCI were a reduction of 2.5 (95% CI: 1.1–4.5, p = 0.001) and 5.1
(95% CI: 2.6–9.8, p < 0.001) percentage points, respectively. The
corresponding estimates for the effects on deaths due to de-
mentia among women living with dementia at baseline were a
decrease of 13.9 (95% CI: 3.4–26.3, p = 0.011) and 52.3 (95%
CI: 9.2–97.9, p = 0.018) percentage points. For both MCI and
deaths due to dementia, the estimates among men were statis-
tically indistinguishable from zero. Formal interaction tests by
gender showed that the interaction was significant for both
new MCI diagnoses (p = 0.029) and deaths due to dementia
(p = 0.039) (Table S1). The significant effects among women
were robust across different choices of bandwidth, grace period,
and functional form (using local quadratic instead of local linear
regression), as well as when requiring that a new MCI diagnosis
not be followed by a new dementia diagnosis within 0–3 months
or within 0–6 months, adjusting for the staggered rollout of the
program, adjusting for indicators of health service utilization,
and restricting the analysis cohort to frequent primary care visi-
tors (Figure S5).
To examine whether the benefits of HZ vaccination in reducing
deaths due to dementia also apply to those who already have
more advanced dementia, we additionally conducted a set of
subgroup analyses that divided those living with dementia at
the time of the start date of the HZ vaccination program into
those with more versus less severe dementia. To do so, we
used several indicators—as measured prior to September 1,
2013—that we hypothesized likely reflect dementia severity: (1)
risk of all-cause mortality, as predicted from each condition
that is part of the Charlson comorbidity index
46
; (2) the total num-
ber of days spent as an inpatient in hospital (as part of admis-
sions for which dementia was recorded as a primary or second-
ary reason); (3) the number of hospital admissions (for which
dementia was recorded as a primary or secondary reason); (4)
the number of times that a diagnosis of dementia was recorded
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 45.9
95% CI: [44.7,47.8]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 43.6
95% CI: [41.8,46.1]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Coef.: 50.5
95% CI: [48.8,52.9]
p<0.001
Full population Women Men
−156 −104 −52 0 52 104 156
−156 −104 −52 0 52 104 156 −156 −104 −52 0 52 104 156
0
20
40
60
80
Week of birth (relative to Sept 2 1933)
Ever had the HZ vaccine (in %)
0.00 0.25 0.50 0.75 1.00
Weight
Among patients without cognitive impairment at baseline
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 28.7
95% CI: [23.9,35.5]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 26.5
95% CI: [20.8,34.4]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Coef.: 32.0
95% CI: [25.1,41.0]
p<0.001
Full population Women Men
−156 −104 −52 0 52 104 156 −156 −104 −52 0 52 104 156 −156 −104 −52 0 52 104 156
0
20
40
60
80
Week of birth (relative to Sept 2 1933)
Ever had the HZ vaccine (in %)
0.00 0.25 0.50 0.75 1.00
Wei ght
Among patients living with dementia at baseline
Figure 1. The abrupt change in the probability of receiving the HZ vaccination at the September 2, 1933, date-of-birth eligibility threshold
‘Baseline’ refers to the start date of the HZ vaccination program (i.e., September 1, 2013). Linear regression lines were drawn in the mean squared error-optimal
bandwidth only. Gray dots show the mean value for each 10-week increment in week of birth. The gray shading of the dots is in proportion to the weight that
observations from this 10-week increment received in the analysis.
Abbreviations are as follows: HZ, herpes zoster; Coef., coefficient; CI, confidence interval; Sept, September.
See also Figure S10.
ll
OPEN ACCESS
6 Cell 188, 1–16, December 11, 2025
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
in the electronic health record from primary, secondary, or ter-
tiary care; and (5) risk of death due to dementia, as predicted
from the variables defined in (2) and (4), as well as each condition
that is part of the Charlson comorbidity index.
46
Although not
reaching statistical significance, directionally we found tentative
evidence that the protective effect, both on an absolute and rela-
tive scale, of HZ vaccination on deaths due to dementia was
greater for those with more advanced dementia (Figures S6
and S7).
Exploratory analyses by type of dementia
We conducted a set of exploratory analyses to provide sugges-
tive evidence of which type of dementia is most strongly affected
by HZ vaccination. To do so, we focused on women because our
heterogeneous treatment effect analyses presented in the pre-
ceding section found that effects were largely driven by this
group. Given that different dementia types vary in their inci-
dence, we compared relative rather than absolute effects. This
required a focus on point estimates because there is no estab-
lished method to estimate CIs and p values for relative effects
in a regression discontinuity approach.
42
We relied on hospital-
based diagnoses as opposed to primary care diagnoses
because these are more likely to be based on a thorough assess-
ment that also includes brain imaging.
47
To maintain adequate
sample sizes, we limited our comparison to diagnoses of the
three most common types of dementia in our data, which were
Alzheimer’s disease, vascular dementia, and mixed dementia.
Our analyses examined the effect of HZ vaccination receipt
and eligibility on dementia diagnoses by type for both women
without a dementia diagnosis at baseline (i.e., the same analysis
cohort as used in Eyting et al.
24
) as well as those without cogni-
tive impairment at baseline (i.e., the same analysis cohort as
used for our MCI outcome analysis). We also examined only
those dementia diagnoses that were made subsequent to an
MCI diagnosis during the follow-up period. As shown in
Table S2, the relative reductions in dementia incidence from
HZ vaccination receipt and eligibility were generally largest for
diagnoses of mixed dementia as opposed to diagnoses of Alz-
heimer’s disease and diagnoses of vascular dementia.
The protective effect for dementia deaths resulted in a
reduction in all-cause mortality
Among patients living with dementia at baseline, being eligible for
HZ vaccination (based on being born immediately after versus
immediately before September 2, 1933) decreased all-cause
mortality over our 9-year follow-up period by 6.5 (95% CI: 2.1–
12.5, p = 0.006) percentage points (Figure 5). Adjusted for the pro-
portion who took up HZ vaccination if they were eligible using our
Effect on MCI
Effect of vaccination eligibility
Effect of vaccine receipt
−1.5 (−2.9, −0.5)
−3.1 (−6.2, −1.0)
0.006
0.007
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−5 0 5
Regression discontinuity
Effect on deaths due to dementia
Effect of vaccination eligibilityEffect of vaccination eligibility
Effect of vaccine receiptEffect of vaccine receipt
−8.5 (−18.5, −0.6)
−8.9 (−16.0, −1.8)
−29.5 (−62.9, −0.6)
−34.6 (−62.4, −6.7)
0.036
0.014
0.046
0.015
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−50 0 50
Regression discontinuity
Difference−in−diff
erences
Figure 2. The effect of HZ vaccination on new diagnoses of MCI and deaths due to dementia
Dots show the point estimate and horizontal bars the 95% CI. New diagnoses of MCI were analyzed among a study cohort of patients who did not have any record
of cognitive impairment prior to the start date of the HZ vaccination program. Deaths due to dementia were analyzed among a study cohort of patients who had
received a diagnosis of dementia prior to the start date of the HZ vaccination program.
Abbreviations are as follows: MCI, mild cognitive impairment; CI, confidence interval.
See also Figures S2S4.
ll
OPEN ACCESS
Cell 188, 1–16, December 11, 2025 7
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
regression discontinuity approach, the effect of actually receiving
the HZ vaccination was a 22.7 (95% CI: 6.5–42.8, p = 0.008) per-
centage point reduction in all-cause mortality over 9 years. There
was no significant effect of HZ vaccination eligibility or receipt on
non-dementia deaths. As for deaths due to dementia, the effects
of HZ vaccination eligibility and receipt on all-cause mortality
were larger among women and statistically indistinguishable
from zero among men (Figure S8). All results were similar when
using a difference-in-differences instead of a regression discon-
tinuity approach. Both among the whole sample and among
women only, the effect on all-cause mortality was robust across
different choices of bandwidth and grace period, as well as
when using local quadratic instead of local linear regression—ad-
justing for the staggered rollout of the program—and when add-
ing a dichotomous covariate that indicated whether an individual
had been diagnosed with ischemic heart disease prior to the start
date of the HZ vaccination program (Figure S9).
DISCUSSION
We found that live-attenuated HZ vaccination reduced both new
diagnoses of MCI among those without any record of cognitive
Indicators of preventive health services uptake
Leading causes of morbidity and mortality
Antihypertensive medication use
Breast cancer screening
Influenza vaccination
Statin use
Breast cancer
COPD
Colorectal cancer
Diabetes mellitus
Ischemic heart disease
Lower respiratory tract infection
Lung cancer
Pancreatic cancer
Stroke
0.8 (−0.9, 2.6)
1.1 (−0.2, 2.6)
0.5 (−1.3, 2.1)
0.2 (−1.3, 2.0)
0.4 (−0.4, 1.2)
−0.1 (−1.2, 0.9)
0.0 (−0.6, 0.6)
0.6 (−0.2, 1.4)
0.5 (−0.2, 1.5)
−0.8 (−2.8, 1.0)
0.3 (−0.2, 1.0)
−0.1 (−0.5, 0.3)
−0.5 (−1.6, 0.5)
0.354
0.104
0.638
0.680
0.294
0.773
0.904
0.166
0.146
0.338
0.226
0.635
0.326
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−10 −5 0 5 10
Among patients without cognitive impairment at baseline
Indicators of preventive health services uptake
Leading causes of mortality
Antihypertensive medication use
Breast cancer screening
Influenza vaccination
Statin use
Breast cancer
COPD
Colorectal cancer
Diabetes mellitus
Ischemic heart disease
Lower respiratory tract infection
Lung cancer
Pancreatic cancer
Stroke
1.4 (−7.2, 10.0)
1.6 (−2.4, 6.5)
0.6 (−7.9, 8.0)
−4.2 (−12.3, 2.3)
−0.3 (−2.1, 1.4)
−0.2 (−2.7, 1.8)
−0.6 (−2.1, 0.5)
−0.7 (−2.0, 0.8)
0.3 (−1.5, 2.4)
−0.3 (−3.7, 3.0)
0.2 (−1.2, 2.0)
0.0 (−0.8, 0.7)
1.9 (−1.7, 5.0)
0.746
0.361
0.990
0.177
0.693
0.696
0.230
0.367
0.651
0.829
0.624
0.852
0.325
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−10 −5 0 5 10
Among patients living with dementia at baseline
Figure 3. No significant effect of being eligible for HZ vaccination on the leading causes of morbidity and mortality (other than dementia) nor
on indicators of preventive health services uptake
Baseline refers to the start date (September 1, 2013) of the HZ vaccination program. Dots show the point estimate and horizontal bars the 95% CI. Among patients
without a record of cognitive impairment prior to the start date of the HZ vaccination program, the leading causes of morbidity and mortality were the ten (other
than dementia) leading causes of DALYs and mortality among adults aged 70+ years in Wales, as estimated by the Global Burden of Disease Project.
44
Among
patients with a diagnosis of dementia made prior to the start date of the HZ vaccination program, the leading causes of mortality were the ten (other than de-
mentia) leading causes of mortality among adults aged 70+ years in Wales, as estimated by the Global Burden of Disease Project.
44
Among patients without a
record of cognitive impairment prior to the start date of the HZ vaccination program, a new diagnosis of a given condition was defined as the diagnosis being
recorded for the first time in our electronic health record data or as an underlying or contributing cause on the death certificate. Among patients with a diagnosis of
dementia made prior to the start date of the HZ vaccination program, a death was considered to be caused by a given condition if it was recorded as the un-
derlying cause of death on the death certificate. Influenza vaccination was defined as receipt of influenza vaccination at any time in the 12 months after the start
date of the HZ vaccination program. Statin and antihypertensive medication use was defined as any prescription of these medications during the 12 months after
the start date of the HZ vaccination program. Breast cancer screening and diagnoses were analyzed among women only. Breast cancer screening was defined as
a record of referral to, attendance at, or a report from ‘breast cancer screening’’ or mammography at any time after the start date of the HZ vaccination program.
The Read and ICD (International Classification of Diseases) codes used to define each variable shown in this figure are provided in Data S1.
Abbreviations are as follows: COPD, chronic obstructive pulmonary disease; CI, confidence interval.
ll
OPEN ACCESS
8 Cell 188, 1–16, December 11, 2025
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
impairment and deaths due to dementia among patients living
with dementia. The HZ vaccine thus appears to have a beneficial
effect at both ends of the clinical disease course of dementia.
Although our point estimates indicate large effect sizes, the
exact magnitude of the effect was difficult to ascertain in this
analysis, given the wide CIs around our estimates. The lower sta-
tistical power compared with standard associational analyses
was a result of our focus on individuals born in close proximity
to the September 2, 1933, date-of-birth threshold.
Our findings suggest that HZ vaccination could be an effective
intervention to prevent or delay MCI and dementia, as well as to
reduce disease progression among those living with dementia.
Such a beneficial effect also appears to exist among those
who already have more advanced dementia, based on our
finding that the reductions in deaths due to dementia from HZ
vaccination tended to be larger among those with more versus
less severe dementia. Using the same quasi-randomization
approach as in this study, our group has previously shown that
HZ vaccination reduced new diagnoses of dementia in both
Wales as well as Australia.
24,37
This effect could have been
observed as a result of HZ vaccination decreasing the transition
from cognitively unimpaired to MCI, from MCI to dementia, or
(because of the delay in diagnosing dementia in the health sys-
tem
48–52
) from undiagnosed to diagnosed dementia. This pre-
sent study suggests that the HZ vaccine acts along the entire
clinical disease course of dementia and thus that our previously
reported effects were due to a decrease in the transition along
each of these dementia disease stages.
Given that it is a readily available, relatively inexpensive,
53–55
one-off, and safe intervention, the finding that HZ vaccination
has a beneficial effect on the dementia disease process would
be of great significance to population health, clinical medicine,
and dementia research. Thus, confirming our previously re-
ported findings from Wales and Australia is critical. In our view,
it is key that such confirmatory studies utilize natural experi-
ments because more standard associational analyses may
lead to false confirmations as a result of confounding, such as
the healthy vaccinee bias (i.e., the common observation
that healthier, more health-motivated individuals opt to be vacci-
nated
36
). Our quasi-randomized approach is far less vulnerable
to these biases because health status, health-related motivation,
and other dementia-related characteristics are unlikely to differ
between individuals born just before versus just after a specific
date-of-birth eligibility threshold. Therefore, in addition to its
principal finding that the HZ vaccine appears to act along the
entire clinical disease course of dementia, an important contribu-
tion of this present study is that it confirms our previously re-
ported findings in two different study populations (those without
any record of cognitive impairment and those living with demen-
tia) and using two different dementia-related outcomes (MCI and
deaths due to dementia). Deaths with dementia as their primary
cause among individuals living with dementia is a particularly
Men
W
omen
Effect of vaccination eligibility
Effect of vaccine receipt
Effect of vaccination eligibility
Effect of vaccine receipt
−0.2 (−1.7, 1.4)
−0.7 (−4.1, 2.5)
−2.5 (−4.5, −1.1)
−5.1 (−9.8, −2.6)
0.846
0.650
0.001
< 0.001
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−15 −10 −5 0 5
Regression discontin
uity
Effect on MCI
Men
W
omen
Effect of vaccination eligibilityEffect of vaccination eligibility
Effect of vaccine receiptEffect of vaccine receipt
Effect of vaccination eligibilityEffect of vaccination eligibility
Effect of vaccine receiptEffect of vaccine receipt
1.3 (−12.4, 13.0)
0.4 (−11.0, 11.8)
4.3 (−40.1, 41.6)
1.4 (−38.9, 41.7)
−13.9 (−26.3, −3.4)
−14.9 (−23.9, −5.8)
−52.3 (−97.9, −9.2)
−62.1 (−101.5, −22.7)
0.966
0.944
0.970
0.944
0.011
0.001
0.018
0.002
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−100 −50 0 50
Regression discontinuity
Difference−in−diff
erences
Effect on deaths due to dementia
Figure 4. The effect of HZ vaccination on new diagnoses of MCI and deaths due to dementia separately by gender
Dots show the point estimate and horizontal bars the 95% CI. New diagnoses of MCI were analyzed among a study cohort of patients who did not have any record
of cognitive impairment prior to the start date of the HZ vaccination program. Deaths due to dementia were analyzed among a study cohort of patients who had
received a diagnosis of dementia prior to the start date of the HZ vaccination program.
Abbreviations are as follows: MCI, mild cognitive impairment; CI, confidence interval.
See also Figures S5S7.
ll
OPEN ACCESS
Cell 188, 1–16, December 11, 2025 9
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
opportune outcome in this regard because it is directly related to
dementia but less reliant on a timely diagnosis of dementia in the
health system, given that dementia is likely to be readily apparent
by the time that it is the primary cause of death. Similarly, our
secondary outcome of all-cause mortality among individuals
living with dementia at baseline is entirely independent of the
health system’s process for diagnosing dementia. These mortal-
ity outcomes are thus largely measured differently than new di-
agnoses of dementia. In our view, being able to confirm the ben-
efits of HZ vaccination for dementia using a set of outcomes that
are all related to dementia but measured differently, strengthens
the evidence that HZ vaccination has an effect on the dementia
disease process itself rather than only its measurement (e.g., a
diagnostic pathway).
We found that, among individuals living with dementia at base-
line, HZ vaccination did not only lead to a decrease in deaths due
to dementia but also a reduction in overall mortality. Specifically,
we observed a decrease, which was larger among women than
men, in both deaths due to dementia and all-cause mortality, but
no effect on deaths for which dementia was not mentioned as the
underlying or a contributing cause on the death certificate. Our
findings thus imply that HZ vaccination among individuals living
with dementia increased remaining life expectancy. This reduc-
tion in deaths due to dementia is unlikely to be a result of averted
shingles episodes, given that shingles has a low mortality rate.
56
Instead, this study suggests that the HZ vaccine may slow de-
mentia disease progression. Nonetheless, identifying the exact
mechanism for this effect is, in our view, an important area of
future research.
For each of our outcomes, we found that the protective effect of
HZ vaccination was larger among women than men. We
observed the same gender effect heterogeneity in our previous
study in Wales for new diagnoses of dementia.
57
However,
although none of our results were statistically significant among
men, we cannot exclude the possibility of substantial beneficial
effects among men as well, given the width of our CIs. A strong
gender effect heterogeneity, with beneficial effects usually being
more pronounced among females, has frequently been observed
for off-target effects of vaccines.
20
Our observed effect heteroge-
neity between women and men may thus reflect immunological
sex differences. These immunological sex differences may be
pathogen independent but could also be specific to the interac-
tion of the immune system with the varicella zoster virus.
58
The
occurrence of shingles has, for instance, been reported to be
more common among women in several studies.
59,60
Addition-
ally, it is equally possible that our observed gender effect hetero-
geneity reflects differences in the pathophysiology of some types
of dementia between women and men: an area that has received
increasing research interest in recent years.
61–63
We did not
observe a significant gender effect heterogeneity in our analysis
of primary care data from Australia.
37
We believe that this is likely
due to limited statistical power, stemming from the fact that,
compared with our data from Wales, our Australian data con-
tained substantially fewer patients, the abrupt increase in the
probability of receiving the HZ vaccination at the date-of-birth
eligibility threshold was smaller, and the incidence of new de-
mentia diagnoses in the data was lower.
The key strength of this study is its quasi-randomized design.
Prior to our analysis in Wales, all epidemiological studies on
the relationship between vaccines and dementia had simply
compared vaccine recipients with non-recipients while attempt-
ing to control for the myriad of characteristics that differ between
those who opt to be vaccinated versus those who do not.
26–35
Electronic health record data do not have detailed information
on health behaviors—such as physical activity and diet
64,65
that are known to be linked to other health behaviors (including
vaccination) as well as dementia. These studies are thus vulner-
able to confounding.
66
Our approach is fundamentally different
in that we compare individuals who were ineligible or eligible for
HZ vaccination because they were born just before or just after
All−cause mortality
Non−dementia deaths
Deaths due to dementia
EEEffffffeeeccct tt ooof ff vvvaaacccccciiinnnaaatttiiiooon nn eeellliiigggiiibbbiiillliiitttyyy
EEEffffffeeeccct tt ooof ff vvvaaacccccciiinnne ee rrreeeccceeeiiipppttt
EEEffffffeeeccct tt ooof ff vvvaaacccccciiinnnaaatttiiiooon nn eeellliiigggiiibbbiiillliiitttyyy
EEEffffffeeeccct tt ooof ff vvvaaacccccciiinnne ee rrreeeccceeeiiipppttt
EEEffffffeeeccct tt ooof ff vvvaaacccccciiinnnaaatttiiiooon nn eeellliiigggiiibbbiiillliiittty
yy
EEEffffffeeeccct tt ooof ff vvvaaacccccciiinnne ee rrreeeccceeeiiipppttt
−6.5 (−12.5, −2.1)
−4.8 (−9.2, −0.5)
−22.7 (−42.8, −6.5)
−18.8 (−35.7, −1.9)
0.5 (−6.3, 7.2)
1.2 (−4.8, 7.2)
1.9 (−22.5, 25.3)
4.6 (−18.8, 27.9)
−8.5 (−18.5, −0.6)
−8.9 (−16.0, −1.8)
−29.5 (−62.9, −0.6)
−34.6 (−62.4, −6.7)
0.006
0.030
0.008
0.030
0.904
0.701
0.909
0.702
0.036
0.014
0.046
0.015
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−100 −50 0 50
Regression discontinuity
Difference−in−differences
Figure 5. The effect of HZ vaccination on deaths due to dementia, non-dementia deaths, and all-cause mortality
Dots show the point estimate and horizontal bars the 95% CI. Deaths due to dementia were analyzed among a study cohort of patients who had received a
diagnosis of dementia prior to the start date of the HZ vaccination program. Non-dementia deaths were defined as deaths for which dementia was recorded as
neither the underlying nor a contributing cause of death in the death certificate.
Abbreviation is as follows: CI, confidence interval.
See also Figures S8 and S9.
ll
OPEN ACCESS
10 Cell 188, 1–16, December 11, 2025
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
the date-of-birth eligibility threshold (September 2, 1933) for HZ
vaccination. On average, individuals in Wales born in one week
versus merely a week later would not be expected to differ in their
health characteristics and behaviors. In the case of the
September 2, 1933, threshold, however, there was a large differ-
ence in the probability of ever receiving the HZ vaccine between
these groups, who differed in age by merely a week. The eligibility
rules of the HZ vaccination program in Wales thus created two
comparison groups—just on either side of the September 2,
1933, threshold—who were (after flexibly controlling for age)
likely similar to each other except for their probability of receiving
the intervention of interest (HZ vaccination). As a result, the
findings from our analysis are more likely to reflect a causal rela-
tionship than are those from the associational epidemiological
evidence (Figures S10 and S11).
26–35,67,68
The critical advantage of our quasi-randomization approach
is that a confounding variable can only bias our analysis if it
changes abruptly at the September 2, 1933, date-of-birth
threshold.
41,42
Such an abrupt change in a confounding variable
at the September 2, 1933, date-of-birth threshold might exist if
there were another intervention that used the identical date-of-
birth threshold as its eligibility criterion as did the HZ vaccination
program. We conducted a series of tests to investigate whether
the existence of such an intervention is likely. Specifically, individ-
uals born just on either side of the September 2, 1933, date-of-
birth threshold were well-balanced at baseline in their past pre-
ventive health services uptake, prevalence of common causes
of morbidity and mortality, and past incidence of MCI and deaths
due to dementia. Similarly, there was no effect of the September
2, 1933, date-of-birth threshold on common health outcomes
(other than dementia) during our 9-year follow-up period, nor on
preventive health services uptake indicators (other than HZ
vaccination). Lastly, the September 2 date-of-birth threshold
only had an effect on MCI and deaths due to dementia in the birth
year (1933) that was used by the HZ vaccination program as its
eligibility criterion. Thus, none of our tests suggested the exis-
tence of another intervention that also used the date of birth of
September 2, 1933, as its eligibility criterion. It is in our view
also unlikely that HZ vaccination led to increased uptake of other
preventive health services (e.g., the uptake of other vaccines at
the same visit) because we did not observe any effect of HZ
vaccination eligibility on available indicators of preventive health
services among older adults in our data.
We believe that our repeated findings from natural experiment
studies of a beneficial effect of HZ vaccination on the dementia
disease process call for further investments in this area of
research, not only to confirm the effects but also to elucidate
the mechanisms. Although only suggestive, our exploratory ana-
lyses showing larger relative reductions for mixed dementia than
for Alzheimer’s disease and vascular dementia point to a mecha-
nism that is at play in both Alzheimer’s disease and vascular de-
mentia—and potentially other dementia types as well. Several
such potential mechanisms have been outlined recently,
9
and
these suggest that HZ vaccination may protect neuroimmune
health in older age more broadly as well as counteracting immu-
nosenescence. There is also evidence that reactivations of the
varicella zoster virus can lead to long-lasting cognitive impairment
through vasculopathy,
69,70
amyloid deposition and aggregation of
tau proteins,
10
and neuroinflammation,
13–16
as well as a pattern of
cerebrovascular disease that is similar to that seen in Alzheimer’s
disease, such as small- to large-vessel disease, ischemia, infarc-
tion, and hemorrhage.
11–16
In addition, reactivations of the vari-
cella zoster virus may lead to reactivations of the herpes simplex
virus in the brain.
71,72
This finding, in turn, would link HZ vaccina-
tion to the more extensive literature on the herpes simplex virus as
a causative factor in the development of dementia.
3,73
A recent
analysis of electronic health record data from the United States
found that indicators of a higher burden of reactivations of the vari-
cella zoster virus were associated with an increased risk of de-
mentia.
68
Specifically, the authors reported a consistent pattern
of a higher burden of varicella zoster virus reactivations (as as-
sessed by comparing dementia risk in those with multiple versus
single shingles episodes) being associated with a higher dementia
risk, whereas a lower burden (as assessed by comparing demen-
tia risk in those who received an HZ vaccine versus those who
received a pneumococcal vaccine, two doses versus one dose
of the recombinant subunit HZ vaccine, and the live-attenuated
versus the recombinant subunit HZ vaccine) was associated
with a lower dementia risk. The analysis also found that the pro-
tective association of HZ vaccination with dementia risk was
largest among women and older patients—groups who are at a
higher risk of shingles.
59,60,74
Importantly, however, although find-
ings were consistent across analyses, each analysis is subject to
the risk of residual confounding and thus correlational in nature
only. It may also, therefore, be the case that a pathogen-indepen-
dent immunomodulatory mechanism is involved, as possibly sug-
gested by our repeated finding of a strong effect heterogeneity by
gender.
20
Some of these potential immune mechanisms have
recently been described elsewhere.
17,18
Limitations of the study
This study has several important limitations. First, our findings
pertain to those age groups born near to the September 2,
1933, date-of-birth threshold (primarily those aged 79–80 years).
It is possible that the protective effects observed in this study do
not exist, or are of a different magnitude, in younger age groups,
given that the neuropathology and pathophysiology of dementia
varies strongly by age.
75–79
In addition, the immune system ap-
pears to change in a multitude of characteristics during the last
decades of life,
80
which could influence any role that the varicella
zoster virus or a virus-independent immunomodulatory effect
induced by the live-attenuated HZ vaccine may have in the de-
mentia disease process. Another reason that effects of the HZ
vaccine on dementia-related outcomes may differ by age is
that the efficacy of the live-attenuated HZ vaccine for preventing
HZ is lower in older than in younger age groups.
58,81
Second,
given its implementation using local linear regression, regression
discontinuity is only able to reliably estimate absolute as
opposed to relative effects.
41,82
Third, we were limited to infor-
mation contained in electronic health record and death certifi-
cate data to define our study cohorts and outcomes. It is likely
that there is considerable underascertainment in our data for
cognitive impairment (to define the cognitively unimpaired study
cohort for our first aim), dementia (to define the study cohort of
individuals living with dementia for our second aim), MCI, and
deaths due to dementia. Crucially, however, the degree of
ll
OPEN ACCESS
Cell 188, 1–16, December 11, 2025 11
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
underascertainment (as well as any delay in making these diag-
noses or in changes in data quality over time) is unlikely to differ
between individuals born just before versus just after September
2, 1933. As such, other than potential underestimation of the
true benefits of HZ vaccination on an absolute scale, underas-
certainment of these variables was unlikely to bias our analysis.
Fourth, we were also limited to the information available in
electronic health record data to define the two stages of the dis-
ease course of dementia analyzed in this study. We, for instance,
had no information on β-amyloid or tau pathology or results from
detailed neuropsychological assessments. Fifth, the COVID-19
pandemic started within our follow-up period and may have de-
layed new diagnoses of MCI as well as changed mortality rates
among individuals living with dementia. However, as for our third
limitation, the pandemic affected individuals born just on either
side of the September 2, 1933, date-of-birth threshold equally.
Sixth, some diagnoses of MCI in our data may have mistakenly
been made for individuals who already had mild-to-moderate
dementia. We believe that this is unlikely to be a major limitation
of our analysis, given that our effect estimates remained signifi-
cant when requiring that a new diagnosis of MCI not be followed
by a new diagnosis of dementia within 3 months or within 6
months. Seventh, we observed an imbalance in past ischemic
heart disease diagnoses across the September 2, 1933,
threshold among the study cohort for our second aim. We, how-
ever, show in Tables S1 and S2 that our results were robust to
any adjustment for this imbalance. In our view, this imbalance
was likely a chance finding, given that it was the only difference
with a p value less than 0.05 in 36 (18 among each of our two
study cohorts) baseline balance tests that we conducted. Lastly,
our results pertain to the live-attenuated HZ vaccine (Zostavax,
Merck) only, because the newer recombinant HZ vaccine (Shing-
rix, GSK) was introduced into the UK’s National Health Service
after our follow-up period ended.
83
Conclusions
In conclusion, this study suggests that HZ vaccination slows or
prevents disease progression across the entire disease course
(as far as it can be feasibly ascertained from electronic health re-
cord data) of dementia. By taking advantage of the fact that the
UK’s National Health Service assigned individuals who differed
in their age by just a few weeks to being eligible or ineligible for
HZ vaccination based on their date of birth, we were able to
generate evidence that is more likely to be causal than those
from more standard epidemiological analyses. Our finding that
HZ vaccination had a beneficial effect on two different demen-
tia-related outcomes in two different patient samples—and at
two opposing ends of the disease course of dementia—thus pro-
vides promising evidence that HZ vaccination may prevent or
slow the dementia disease process in a substantial proportion
of individuals.
RESOURCE AVAILABILITY
Lead contact
Requests for further information and resources should be directed to, and will
be fulfilled by, the lead contact, Pascal Geldsetzer (pgeldsetzer@stanford.
edu).
Materials availability
This study did not generate new unique reagents.
Data and code availability
The data that support the findings of this study are available from the
SAIL databank.
38
Researchers must request access to the data directly
from SAIL. The authors have no permission to share the data.
All statistical analysis code (in R) has been deposited in a publicly
accessible OSF repository at https://osf.io/nwz8h/?view_only=2311
79cb8d7045f3be22b0979634d9c3. All Read and ICD codes to define
variables are available in Data S1.
Any additional information required to reanalyze the data reported in this
paper is available from the lead contact upon request.
ACKNOWLEDGMENTS
This study makes use of anonymized data held in the SAIL databank. The au-
thors are grateful for the continuous advice and support from the SAIL data-
bank analytical services team throughout all stages of the project. We would
also like to acknowledge all the data providers who made anonymized data
available for our research. The responsibility for the interpretation of the data
supplied by SAIL is the authors’ alone. SAIL bears no responsibility for the
further analysis or interpretation of their data over and above that published
by SAIL.
This study was funded by grants to P.G. by The Phil & Penny Knight Initiative
for Brain Resilience at the Wu Tsai Neurosciences Institute, Stanford University
(KPI-003); the National Institute on Aging (R01AG084535); National Institute of
Allergy and Infectious Diseases (DP2AI171011); and Chan Zuckerberg
Biohub-San Francisco. The funders had no role in the design and conduct of
the study; collection, management, analysis, and interpretation of the data;
preparation, review, or approval of the manuscript; or the decision to submit
the manuscript for publication.
AUTHOR CONTRIBUTIONS
M.X. and M.E. devised the methodology, analyzed and processed the data,
created data visualizations, interpreted the results, and reviewed and edited
the original draft. C.B. co-devised the methodology, interpreted the results,
and reviewed and edited the original draft. H.A. interpreted the results and
reviewed and edited the original draft. P.G. conceived the overall project,
acquired funding, conceived the study, devised the methodology, was respon-
sible for administration and supervision, interpreted the results, wrote the orig-
inal draft, and reviewed and edited the original draft.
DECLARATION OF INTERESTS
The authors declare no competing interests.
STARMETHODS
Detailed methods are provided in the online version of this paper and include
the following:
KEY RESOURCES TABLE
EXPERIMENTAL MODEL AND STUDY PARTICIPANT DETAILS
Human participants
METHOD DETAILS
Study cohorts and follow-up period
Exposure and outcome definition
Ethics
QUANTIFICATION AND STATISTICAL ANALYSIS
Regression discontinuity analysis
Testing for confounding
Testing for ascertainment bias
Evidence triangulation
Effect heterogeneity analyses
Regression equations
ll
OPEN ACCESS
12 Cell 188, 1–16, December 11, 2025
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
SUPPLEMENTAL INFORMATION
Supplemental information can be found online at https://doi.org/10.1016/j.cell.
2025.11.007.
Received: April 13, 2025
Revised: September 16, 2025
Accepted: November 5, 2025
REFERENCES
1. Bettcher, B.M., Tansey, M.G., Dorothe
´
e, G., and Heneka, M.T. (2021).
Peripheral and central immune system crosstalk in Alzheimer disease -
a research prospectus. Nat. Rev. Neurol. 17, 689–701. https://doi.org/
10.1038/s41582-021-00549-x.
2. Itzhaki, R.F., Lathe, R., Balin, B.J., Ball, M.J., Bearer, E.L., Braak, H., Bul-
lido, M.J., Carter, C., Clerici, M., Cosby, S.L., et al. (2016). Microbes and
Alzheimer’s Disease. J. Alzheimers Dis. 51, 979–984. https://doi.org/10.
3233/JAD-160152.
3. Devanand, D.P. (2018). Viral Hypothesis and Antiviral Treatment in Alz-
heimer’s Disease. Curr. Neurol. Neurosci. Rep. 18, 55. https://doi.org/
10.1007/s11910-018-0863-1.
4. Moir, R.D., Lathe, R., and Tanzi, R.E. (2018). The antimicrobial protection
hypothesis of Alzheimer’s disease. Alzheimers Dement. 14, 1602–1614.
https://doi.org/10.1016/j.jalz.2018.06.3040.
5. Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B.,
Whitley, R., and Yamanishi, K. (2007). Human Herpesviruses: Biology,
Therapy, and Immunoprophylaxis (Cambridge University Press).
6. Eimer, W.A., Vijaya Kumar, D.K., Navalpur Shanmugam, N.K., Rodriguez,
A.S., Mitchell, T., Washicosky, K.J., Gyo
¨
rgy, B., Breakefield, X.O., Tanzi,
R.E., and Moir, R.D. (2018). Alzheimer’s Disease-Associated β-Amyloid
Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection.
Neuron 99, 56–63.e3. https://doi.org/10.1016/j.neuron.2018.06.030.
7. Hyde, V.R., Zhou, C., Fernandez, J.R., Chatterjee, K., Ramakrishna, P.,
Lin, A., Fisher, G.W., C¸ eliker, O.T., Caldwell, J., Bender, O., et al.
(2025). Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1
pathway in Alzheimer’s disease. Cell Rep. 44, 115109. https://doi.org/
10.1016/j.celrep.2024.115109.
8. Soldan, S.S., and Lieberman, P.M. (2023). Epstein–Barr virus and multi-
ple sclerosis. Nat. Rev. Microbiol. 21, 51–64. https://doi.org/10.1038/
s41579-022-00770-5.
9. Huang, X., and Gu, B.J. (2025). Shingles vaccination and neuroimmune
vulnerability. Trends Neurosci. 48, 655–662. https://doi.org/10.1016/j.
tins.2025.07.003.
10. Bubak, A.N., Como, C.N., Hassell, J.E., Mescher, T., Frietze, S.E., Nie-
meyer, C.S., Cohrs, R.J., and Nagel, M.A. (2022). Targeted RNA
Sequencing of VZV-Infected Brain Vascular Adventitial Fibroblasts Indi-
cates That Amyloid May Be Involved in VZV Vasculopathy. Neurol. Neu-
roimmunol. Neuroinflamm. 9, e1103. https://doi.org/10.1212/NXI.
0000000000001103.
11. Attems, J., and Jellinger, K.A. (2014). The overlap between vascular dis-
ease and Alzheimer’s disease–lessons from pathology. BMC Med. 12,
206. https://doi.org/10.1186/s12916-014-0206-2.
12. Boyle, P.A., Yu, L., Nag, S., Leurgans, S., Wilson, R.S., Bennett, D.A., and
Schneider, J.A. (2015). Cerebral amyloid angiopathy and cognitive out-
comes in community-based older persons. Neurology 85, 1930–1936.
https://doi.org/10.1212/WNL.0000000000002175.
13. Nagel, M.A., and Bubak, A.N. (2018). Varicella Zoster Virus Vasculopathy.
J. Infect. Dis. 218, S107–S112. https://doi.org/10.1093/infdis/jiy425.
14. Nagel, M.A., Cohrs, R.J., Mahalingam, R., Wellish, M.C., Forghani, B.,
Schiller, A., Safdieh, J.E., Kamenkovich, E., Ostrow, L.W., Levy, M.,
et al. (2008). The varicella zoster virus vasculopathies: clinical, CSF, im-
aging, and virologic features. Neurology 70, 853–860. https://doi.org/
10.1212/01.wnl.0000304747.38502.e8.
15. Nagel, M.A., Traktinskiy, I., Azarkh, Y., Kleinschmidt-DeMasters, B.,
Hedley-Whyte, T., Russman, A., VanEgmond, E.M., Stenmark, K., Frid,
M., Mahalingam, R., et al. (2011). Varicella zoster virus vasculopathy:
analysis of virus-infected arteries. Neurology 77, 364–370. https://doi.
org/10.1212/WNL.0b013e3182267bfa.
16. Nagel, M.A., Traktinskiy, I., Stenmark, K.R., Frid, M.G., Choe, A., and Gil-
den, D. (2013). Varicella-zoster virus vasculopathy: immune characteris-
tics of virus-infected arteries. Neurology 80, 62–68. https://doi.org/10.
1212/WNL.0b013e31827b1ab9.
17. Bukhbinder, A.S., Ling, Y., Harris, K., Jiang, X., and Schulz, P.E. (2023).
Do vaccinations influence the development of Alzheimer disease?
Hum. Vaccin. Immunother. 19, 2216625. https://doi.org/10.1080/
21645515.2023.2216625.
18. Bulut, O., Kilic, G., Domı´nguez-Andre´ s, J., and Netea, M.G. (2020). Over-
coming immune dysfunction in the elderly: trained immunity as a novel
approach. Int. Immunol. 32, 741–753. https://doi.org/10.1093/intimm/
dxaa052.
19. Benn, C.S., Fisker, A.B., Rieckmann, A., Sørup, S., and Aaby, P. (2020).
Vaccinology: time to change the paradigm? Lancet Infect. Dis. 20,
e274–e283. https://doi.org/10.1016/S1473-3099(19)30742-X.
20. Benn, C.S., Amenyogbe, N., Bjo¨ rkman, A., Domı´nguez-Andre´ s, J., Fish,
E.N., Flanagan, K.L., Klein, S.L., Kollmann, T.R., Kyvik, K.O., Netea,
M.G., et al. (2023). Implications of Non-Specific Effects for Testing,
Approving, and Regulating Vaccines. Drug Saf. 46, 439–448. https://
doi.org/10.1007/s40264-023-01295-3.
21. Aaby, P., Benn, C.S., Flanagan, K.L., Klein, S.L., Kollmann, T.R., Lynn,
D.J., and Shann, F. (2020). The non-specific and sex-differential effects
of vaccines. Nat. Rev. Immunol. 20, 464–470. https://doi.org/10.1038/
s41577-020-0338-x.
22. Adhisivam, B., Kamalarathnam, C., Bhat, B.V., Jayaraman, K., Namachi-
vayam, S.P., Shann, F., McSharry, B., David, P., Raja, and Sundaram, M.
(2025). Effect of BCG Danish and oral polio vaccine on neonatal mortality
in newborn babies weighing less than 2000 g in India: multicentre open
label randomised controlled trial (BLOW2). BMJ 390, e084745. https://
doi.org/10.1136/bmj-2025-084745.
23. McGovern, M.E., and Canning, D. (2015). Vaccination and all-cause child
mortality from 1985 to 2011: global evidence from the Demographic and
Health Surveys. Am. J. Epidemiol. 182, 791–798. https://doi.org/10.
1093/aje/kwv125.
24. Eyting, M., Xie, M., Michalik, F., Heß, S., Chung, S., and Geldsetzer, P.
(2025). A natural experiment on the effect of herpes zoster vaccination
on dementia. Nature 641, 438–446. https://doi.org/10.1038/s41586-
025-08800-x.
25. UK Health Security Agency. (2021). Shingles: guidance and vaccination
programme. Shingles: guidance and vaccination programme. https://
www.gov.uk/government/collections/shingles-vaccination-programme.
26. Harris, K., Ling, Y., Bukhbinder, A.S., Chen, L., Phelps, K.N., Cruz, G.,
Thomas, J., Kim, Y., Jiang, X., and Schulz, P.E. (2023). The Impact of
Routine Vaccinations on Alzheimer’s Disease Risk in Persons 65 Years
and Older: A Claims-Based Cohort Study using Propensity Score Match-
ing. J. Alzheimers Dis. 95, 703–718. https://doi.org/10.3233/JAD-
221231.
27. Lophatananon, A., Mekli, K., Cant, R., Burns, A., Dobson, C., Itzhaki, R.,
and Muir, K. (2021). Shingles, Zostavax vaccination and risk of devel-
oping dementia: a nested case-control study-results from the UK Bio-
bank cohort. BMJ Open 11, e045871. https://doi.org/10.1136/
bmjopen-2020-045871.
28. Scherrer, J.F., Salas, J., Wiemken, T.L., Hoft, D.F., Jacobs, C., and Mor-
ley, J.E. (2021). Impact of herpes zoster vaccination on incident demen-
tia: A retrospective study in two patient cohorts. PLoS One 16, e0257405.
https://doi.org/10.1371/journal.pone.0257405.
ll
OPEN ACCESS
Cell 188, 1–16, December 11, 2025 13
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
29. Schnier, C., Janbek, J., Lathe, R., and Haas, J. (2022). Reduced demen-
tia incidence after varicella zoster vaccination in Wales 2013–2020. Alz-
heimers Dement. (N Y) 8, e12293. https://doi.org/10.1002/trc2.12293.
30. Wiemken, T.L., Salas, J., Morley, J.E., Hoft, D.F., Jacobs, C., and Scher-
rer, J.F. (2022). Comparison of rates of dementia among older adult re-
cipients of two, one, or no vaccinations. J. Am. Geriatr. Soc. 70, 1157–
1168. https://doi.org/10.1111/jgs.17606.
31. Lophatananon, A., Carr, M., Mcmillan, B., Dobson, C., Itzhaki, R., Parisi,
R., Ashcroft, D.M., and Muir, K.R. (2023). The association of herpes zos-
ter and influenza vaccinations with the risk of developing dementia: a
population-based cohort study within the UK Clinical Practice Research
Datalink. BMC Public Health 23, 1903. https://doi.org/10.1186/s12889-
023-16768-4.
32. Ukraintseva, S., Yashkin, A.P., Akushevich, I., Arbeev, K., Duan, H., Gor-
bunova, G., Stallard, E., and Yashin, A. (2024). Associations of infections
and vaccines with Alzheimer’s disease point to a role of compromised
immunity rather than specific pathogen in AD. Exp. Gerontol. 190,
112411. https://doi.org/10.1016/j.exger.2024.112411.
33. Lehrer, S., and Rheinstein, P.H. (2021). Herpes Zoster Vaccination Re-
duces Risk of Dementia. In Vivo 35, 3271–3275. https://doi.org/10.
21873/invivo.12622.
34. Wilkinson, T., Schnier, C., Bush, K., Rannikma¨ e, K., Lyons, R.A., McTag-
gart, S., Bennie, M., and Sudlow, C.L. (2022). Drug prescriptions and de-
mentia incidence: a medication-wide association study of 17000 demen-
tia cases among half a million participants. J. Epidemiol. Community
Health 76, 223–229. https://doi.org/10.1136/jech-2021-217090.
35. Tang, E., Ray, I., Arnold, B.F., and Acharya, N.R. (2024). Recombinant
zoster vaccine and the risk of dementia. Vaccine 46, 126673. https://
doi.org/10.1016/j.vaccine.2024.126673.
36. Remschmidt, C., Wichmann, O., and Harder, T. (2015). Frequency and
impact of confounding by indication and healthy vaccinee bias in obser-
vational studies assessing influenza vaccine effectiveness: a systematic
review. BMC Infect. Dis. 15, 429. https://doi.org/10.1186/s12879-015-
1154-y.
37. Pomirchy, M., Bommer, C., Pradella, F., Michalik, F., Peters, R., and
Geldsetzer, P. (2025). Herpes Zoster Vaccination and Dementia Occur-
rence. JAMA 333, 2083–2092. https://doi.org/10.1001/jama.2025.5013.
38. SAIL Databank. (2024). https://saildatabank.com/.
39. Welsh Longitudinal General Practice Dataset (WLGP) - Welsh Primary
Care. (2023). https://healthdatagateway.org/en/dataset/355.
40. Statistical Directorate (2011). Welsh Index of Multiple Deprivation 2011:
Summary Report (Welsh Government).
41. Cattaneo, M.D., Keele, L., and Titiunik, R. (2023). A guide to regression
discontinuity designs in medical applications. Stat. Med. 42, 4484–
4513. https://doi.org/10.1002/sim.9861.
42. Cattaneo, M.D., Idrobo, N., and Titiunik, R. (2020). A Practical Introduc-
tion to Regression Discontinuity Designs: Foundations (Cambridge Uni-
versity Press).
43. Villamizar-Villegas, M., Pinzon-Puerto, F.A., and Ruiz-Sanchez, M.A.
(2022). A comprehensive history of regression discontinuity designs:
An empirical survey of the last 60 years. J. Econ. Surv. 36, 1130–1178.
https://doi.org/10.1111/joes.12461.
44. Global Burden of Disease Project 2019. (2020). GBD Compare. http://
vizhub.healthdata.org/gbd-compare.
45. Fro
¨
lich, M., and Huber, M. (2019). Including Covariates in the Regression
Discontinuity Design. J. Bus. Econ. Stat. 37, 736–748. https://doi.org/10.
1080/07350015.2017.1421544.
46. Charlson, M.E., Pompei, P., Ales, K.L., and MacKenzie, C.R. (1987). A
new method of classifying prognostic comorbidity in longitudinal studies:
development and validation. J. Chronic Dis. 40, 373–383. https://doi.org/
10.1016/0021-9681(87)90171-8.
47. National Institute for Health and Care Excellence (2018). Dementia:
Assessment, Management and Support for People Living with Dementia
and Their Carers (National Institute for Health and Care Excellence).
48. Lang, L., Clifford, A., Wei, L., Zhang, D., Leung, D., Augustine, G., Danat,
I.M., Zhou, W., Copeland, J.R., Anstey, K.J., et al. (2017). Prevalence and
determinants of undetected dementia in the community: a systematic
literature review and a meta-analysis. BMJ Open 7, e011146. https://
doi.org/10.1136/bmjopen-2016-011146.
49. van Vliet, D., de Vugt, M.E., Bakker, C., Pijnenburg, Y., van Vliet, D., de
Vugt, M.E., Bakker, C., Pijnenburg, Y.A., Vernooij-Dassen, M.J., Koop-
mans, R.T., and Verhey, F.R. (2013). Time to diagnosis in young-onset
dementia as compared with late-onset dementia. Psychol. Med. 43,
423–432. https://doi.org/10.1017/S0033291712001122.
50. Chiari, A., Tondelli, M., Galli, C., Carbone, C., Fiondella, L., Salemme, S.,
Vinceti, G., Bedin, R., Molinari, M.A., and Zamboni, G. (2022). How long
does it take to diagnose young-onset dementia? A comparison with late-
onset dementia. Neurol. Sci. 43, 4729–4734. https://doi.org/10.1007/
s10072-022-06056-1.
51. Chen, Y., Power, M.C., Grodstein, F., Capuano, A.W., Lange-Maia, B.S.,
Moghtaderi, A., Stapp, E.K., Bhattacharyya, J., Shah, R.C., Barnes, L.L.,
et al. (2024). Correlates of missed or late versus timely diagnosis of de-
mentia in healthcare settings. Alzheimers Dement. 20, 5551–5560.
https://doi.org/10.1002/alz.14067.
52. Helvik, A.-S., Engedal, K.,
Saltyt
_
e Benth, J., and Selbæk, G. (2018). Time
from Symptom Debut to Dementia Assessment by the Specialist Health-
care Service in Norway. Dement. Geriatr. Cogn. Dis. Extra 8, 117–127.
https://doi.org/10.1159/000487233.
53. Centers for Disease Control and Prevention. (2022). Archived CDC Vac-
cine Price List as of June 1, 2018. Adult Vaccine Price List. https://www.
cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-
list/2018/2018-06-01.html.
54. Singhal, P.K., and Zhang, D. (2014). Costs of adult vaccination in medical
settings and pharmacies: an observational study. J. Manag. Care Spec.
Pharm. 20, 930–936. https://doi.org/10.18553/jmcp.2014.20.9.930.
55. Prosser, L.A., Harpaz, R., Rose, A.M., Gebremariam, A., Guo, A., Ortega-
Sanchez, I.R., Zhou, F., and Dooling, K. (2019). A Cost-Effectiveness
Analysis of Vaccination for Prevention of Herpes Zoster and Related
Complications: Input for National Recommendations. Ann. Intern. Med.
170, 380–388. https://doi.org/10.7326/M18-2347.
56. Bricout, H., Haugh, M., Olatunde, O., and Prieto, R.G. (2015). Herpes
zoster-associated mortality in Europe: a systematic review. BMC Public
Health 15, 466. https://doi.org/10.1186/s12889-015-1753-y.
57. Eyting, M., Xie, M., Heß, S., and Geldsetzer, P. (2023). Causal evidence
that herpes zoster vaccination prevents a proportion of dementia cases.
Preprint at medRxiv. https://doi.org/10.1101/2023.05.23.23290253.
58. Harbecke, R., Cohen, J.I., and Oxman, M.N. (2021). Herpes Zoster Vac-
cines. J. Infect. Dis. 224, S429–S442. https://doi.org/10.1093/infdis/
jiab387.
59. Fleming, D.M., Cross, K.W., Cobb, W.A., and Chapman, R.S. (2004).
Gender difference in the incidence of shingles. Epidemiol. Infect. 132,
1–5. https://doi.org/10.1017/s0950268803001523.
60. Marra, F., Parhar, K., Huang, B., and Vadlamudi, N. (2020). Risk Factors
for Herpes Zoster Infection: A Meta-Analysis. Open Forum Infect. Dis. 7,
ofaa005. https://doi.org/10.1093/ofid/ofaa005.
61. Ferretti, M.T., Martinkova, J., Biskup, E., Benke, T., Gialdini, G., Nedel-
ska, Z., Rauen, K., Mantua, V., Religa, D., Hort, J., et al. (2020). Sex
and gender differences in Alzheimer’s disease: current challenges and
implications for clinical practice: Position paper of the Dementia and
Cognitive Disorders Panel of the European Academy of Neurology. Eur.
J. Neurol. 27, 928–943. https://doi.org/10.1111/ene.14174.
62. Ferretti, M.T., Iulita, M.F., Cavedo, E., Chiesa, P.A., Schumacher Dimech,
A., Santuccione Chadha, A., Baracchi, F., Girouard, H., Misoch, S., Gia-
cobini, E., et al. (2018). Sex differences in Alzheimer disease - the
ll
OPEN ACCESS
14 Cell 188, 1–16, December 11, 2025
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
gateway to precision medicine. Nat. Rev. Neurol. 14, 457–469. https://
doi.org/10.1038/s41582-018-0032-9.
63. Laws, K.R., Irvine, K., and Gale, T.M. (2018). Sex differences in Alz-
heimer’s disease. Curr. Opin. Psychiatry 31, 133–139. https://doi.org/
10.1097/YCO.0000000000000401.
64. Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Bane-
rjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al.
(2020). Dementia prevention, intervention, and care: 2020 report of the
Lancet Commission. Lancet 396, 413–446. https://doi.org/10.1016/
S0140-6736(20)30367-6.
65. Townsend, R., Fairley, A., Gregory, S., Ritchie, C., Stevenson, E., and
Shannon, O.M. (2024). Nutrition for dementia prevention: a state of the
art update for clinicians. Age Ageing 53, ii30–ii38. https://doi.org/10.
1093/ageing/afae030.
66. Hernan, M.A., and Robins, J.M. (2020). Causal Inference: What If 1st Edi-
tion (Chapman & Hall/CRC).
67. Taquet, M., Dercon, Q., Todd, J.A., and Harrison, P.J. (2024). The recom-
binant shingles vaccine is associated with lower risk of dementia. Nat.
Med. 30, 2777–2781. https://doi.org/10.1038/s41591-024-03201-5.
68. Polisky, V., Littmann, M., Triastcyn, A., Horn, M., Georgiou, A., Widenma-
ier, R., Anspach, B., Tahrat, H., Kumar, S., Buser-Doepner, C., et al.
(2025). Varicella-zoster virus reactivation and the risk of dementia. Pub-
lished online October 6, 2025. Nat. Med. https://doi.org/10.1038/
s41591-025-03972-5.
69. Silver, B., Nagel, M.A., Mahalingam, R., Cohrs, R., Schmid, D.S., and Gil-
den, D. (2012). Varicella zoster virus vasculopathy: a treatable form of
rapidly progressive multi-infarct dementia after 2 years’ duration.
J. Neurol. Sci. 323, 245–247. https://doi.org/10.1016/j.jns.2012.07.059.
70. Gilden, D., Grose, C., White, T., Nagae, L., Hendricks, R.L., Cohrs, R.J.,
and Nagel, M.A. (2016). Successful antiviral treatment after 6years of
chronic progressive neurological disease attributed to VZV brain infec-
tion. J. Neurol. Sci. 368, 240–242. https://doi.org/10.1016/j.jns.2016.
07.035.
71. Cairns, D.M., Itzhaki, R.F., and Kaplan, D.L. (2022). Potential Involvement
of Varicella Zoster Virus in Alzheimer’s Disease via Reactivation of Quies-
cent Herpes Simplex Virus Type 1. J. Alzheimers Dis. 88, 1189–1200.
https://doi.org/10.3233/JAD-220287.
72. Niemeyer, C.S., Frietze, S., Coughlan, C., Lewis, S.W.R., Bustos Lopez,
S., Saviola, A.J., Hansen, K.C., Medina, E.M., Hassell, J.E., Kogut, S.,
et al. (2024). Suppression of the host antiviral response by non-infectious
varicella zoster virus extracellular vesicles. J. Virol. 98, e0084824. https://
doi.org/10.1128/jvi.00848-24.
73. Itzhaki, R.F. (2021). Overwhelming Evidence for a Major Role for Herpes
Simplex Virus Type 1 (HSV1) in Alzheimer’s Disease (AD); Underwhelm-
ing Evidence against. Vaccines (Basel) 9, 679. https://doi.org/10.3390/
vaccines9060679.
74. Insinga, R.P., Itzler, R.F., Pellissier, J.M., Saddier, P., and Nikas, A.A.
(2005). The incidence of herpes zoster in a United States administrative
database. J. Gen. Intern. Med. 20, 748–753. https://doi.org/10.1111/j.
1525-1497.2005.0150.x.
75. Corrada, M.M.M., Jiang, L., Sajjadi, S.A., Montine, T.J., Bukhari, S.A.,
Cholerton, B., Boyle, P.A., Brookmeyer, R., and Kawas, C.H. (2023). Pro-
portion of Dementia Cases in the Oldest-old Attributable to 8 Neuropath-
ological Changes: The 90+ Study. Alzheimers Dement. 19, e074422.
https://doi.org/10.1002/alz.074422.
76. Wong, J., Rajmohan, R., Corrada, M.M.M., and Kawas, C.H. (2023). As-
sociations of Cardiovascular Risk Factors and Cerebrovascular Pathol-
ogies in the Elderly: A Systematic Review. Alzheimers Dement. 19,
e075857. https://doi.org/10.1002/alz.075857.
77. Savva, G.M., Wharton, S.B., Ince, P.G., Forster, G., Matthews, F.E., and
Brayne, C.; Medical Research Council Cognitive Function and Ageing
Study (2009). Age, Neuropathology, and Dementia. N. Engl. J. Med.
360, 2302–2309. https://doi.org/10.1056/NEJMoa0806142.
78. Wang, S.J., Guo, Y., Ervin, J.F., Lusk, J.B., and Luo, S. (2022). Neuro-
pathological associations of limbic-predominant age-related TDP-43 en-
cephalopathy neuropathological change (LATE-NC) differ between the
oldest-old and younger-old. Acta Neuropathol. 144, 45–57. https://doi.
org/10.1007/s00401-022-02432-5.
79. Agrawal, S., and Schneider, J.A. (2022). Vascular pathology and patho-
genesis of cognitive impairment and dementia in older adults. Cereb.
Circ. Cogn. Behav. 3, 100148. https://doi.org/10.1016/j.cccb.2022.
100148.
80. Pinti, M., Appay, V., Campisi, J., Frasca, D., Fu¨ lo¨ p, T., Sauce, D., Larbi,
A., Weinberger, B., and Cossarizza, A. (2016). Aging of the immune sys-
tem: Focus on inflammation and vaccination. Eur. J. Immunol. 46, 2286–
2301. https://doi.org/10.1002/eji.201546178.
81. Oxman, M.N., Levin, M.J., Johnson, G.R., Schmader, K.E., Straus, S.E.,
Gelb, L.D., Arbeit, R.D., Simberkoff, M.S., Gershon, A.A., Davis, L.E.,
et al. (2005). A vaccine to prevent herpes zoster and postherpetic neural-
gia in older adults. N. Engl. J. Med. 352, 2271–2284. https://doi.org/10.
1056/NEJMoa051016.
82. Imbens, G.W., and Lemieux, T. (2008). Regression discontinuity designs:
A guide to practice. J. Econ. 142, 615–635. https://doi.org/10.1016/j.je-
conom.2007.05.001.
83. Pan, C.X., Lee, M.S., and Nambudiri, V.E. (2022). Global herpes zoster
incidence, burden of disease, and vaccine availability: a narrative review.
Ther. Adv. Vaccin. Immunother. 10, 25151355221084535. https://doi.
org/10.1177/25151355221084535.
84. Digital Health, and Care, Wales .. Welsh Demographic Service Dataset
(WDSD). https://healthdatagateway.org/en/dataset/365.
85. NHS England. (2011). NHS Digital Attribution Data Set GP-Registered
Populations Scaled to ONS Population Estimates. https://digital.nhs.
uk/data-and-information/publications/statistical/attribution-dataset-gp-
registered-populations/attribution-data-set-gp-registered-populations-
scaled-to-ons-population-estimates-2011.
86. Digital Health and Care Wales. (2020) Patient Episode Database
for Wales. Digital Health and Care Wales. https://dhcw.nhs.wales/
information-services/health-intelligence/pedw-data-online/.
87. NHS England. (2023). OPCS Classification of Interventions and Proced-
ures. https://www.datadictionary.nhs.uk/supporting_information/opcs_
classification_of_interventions_and_procedures.html.
88. World Health Organization (2004). ICD-10: International Statistical Clas-
sification of Diseases and Related Health Problems, Tenth Revision
(World Health Organization).
89. Digital Health, and Care, Wales. (2022). Outpatient Database for Wales
(OPDW). https://healthdatagateway.org/en/dataset/346.
90. Anderson, M., Pitchforth, E., Edwards, N., Alderwick, H., McGuire, A.,
and Mossialos, E. (2022). United Kingdom: Health System Review.
Health Syst. Transit. 24, 1–194.
91. Public Health Wales. (2023) Welsh Cancer Intelligence and Surveillance
Unit (WCISU). Public Health Wales. https://phw.nhs.wales/services-
and-teams/welsh-cancer-intelligence-and-surveillance-unit-wcisu/.
92. Digital Health, and Care, Wales. (2023). Annual District Death Extract
(ADDE). https://healthdatagateway.org/en/dataset/316.
93. Office for National Statistics. (2024). Office for National Statistics Impact
of registration delays on mortality statistics in England and Wales. https://
www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/
deaths/articles/impactofregistrationdelaysonmortalitystatisticsinenglandand
wales/latest.
94. Office for National Statistics (ONS). (2022). User guide to mortality statistics.
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeaths
andmarriages/deaths/methodologies/userguidetomortalitystatistics
july2017.
95. Ford, D.V., Jones, K.H., Verplancke, J.-P., Lyons, R.A., John, G., Brown,
G., Brooks, C.J., Thompson, S., Bodger, O., Couch, T., et al. (2009). The
SAIL Databank: building a national architecture for e-health research and
ll
OPEN ACCESS
Cell 188, 1–16, December 11, 2025 15
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
evaluation. BMC Health Serv. Res. 9, 157. https://doi.org/10.1186/1472-
6963-9-157.
96. Office for National Statistics (ONS). (2022). User guide to mortality statist-
ics. https://www.ons.gov.uk/peoplepopulationandcommunity/birthdeaths
andmarriages/deaths/methodologies/userguidetomortalitystatisticsjuly
2017.
97. Moran, G.M., Calvert, M., Feltham, M.G., Ryan, R., and Marshall, T.
(2015). A retrospective cohort study to investigate fatigue, psychological
or cognitive impairment after TIA: protocol paper. BMJ Open 5, e008149.
https://doi.org/10.1136/bmjopen-2015-008149.
98. Alzheimer’s Association (2022). 2022 Alzheimer’s disease facts and
figures. Alzheimers Dement. 18, 700–789. https://doi.org/10.1002/
alz.12638.
99. Boyle, P.A., Yu, L., Wilson, R.S., Leurgans, S.E., Schneider, J.A., and
Bennett, D.A. (2018). Person-specific contribution of neuropathologies
to cognitive loss in old age. Ann. Neurol. 83, 74–83. https://doi.org/10.
1002/ana.25123.
100. Boyle, P.A., Yu, L., Leurgans, S.E., Wilson, R.S., Brookmeyer, R.,
Schneider, J.A., and Bennett, D.A. (2019). Attributable risk of Alzheimer’s
dementia attributed to age-related neuropathologies. Ann. Neurol. 85,
114–124. https://doi.org/10.1002/ana.25380.
101. Calonico, S., Cattaneo, M.D., and Titiunik, R. (2014). Robust Nonpara-
metric Confidence Intervals for Regression-Discontinuity Designs. Econ-
ometrica 82, 2295–2326. https://doi.org/10.3982/ECTA11757.
102. Gelman, A., and Imbens, G. (2018). Why High-Order Polynomials Should
Not Be Used in Regression Discontinuity Designs. J. Bus. Econ. Stat. 37,
447–456. https://doi.org/10.1080/07350015.2017.1366909.
ll
OPEN ACCESS
16 Cell 188, 1–16, December 11, 2025
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
STARMETHODS
KEY RESOURCES TABLE
EXPERIMENTAL MODEL AND STUDY PARTICIPANT DETAILS
Human participants
Allocation to exposure groups based on the herpes zoster vaccine rollout in Wales
Starting on September 1 2013, the National Health Service ([NHS], the United Kingdom’s single-payer single-provider healthcare sys-
tem
84
) in Wales made the live-attenuated HZ vaccine (Zostavax, Merck) available to a catch-up cohort of individuals using a stag-
gered rollout system based on specific date-of-birth eligibility thresholds.
25
Individuals who did not yet have their 80
th
birthday on
the start date of the program (i.e., born on or after September 2 1933) were eligible for one year. By contrast, those who had their
80
th
birthday prior to the program start date (i.e., born before September 2 1933) never became eligible.
Specifically, individuals were categorized into three cohorts based on their date of birth: i) a routine cohort consisting of individuals
born on or after September 2 1942 who became eligible when they were 70 years old as of September 1 of a given year of the HZ
vaccination program; ii) a catch-up cohort consisting of individuals born between September 2 1933 and September 1 1942 who
became eligible when they were 79 years (or 78 years, depending on the year of the program) as of September 1 of a given year
of the HZ vaccination program and remained eligible until they were 80 years old (again, as of September 1 of a given year of the
HZ vaccination program); and iii) individuals born on or before September 1 1933 (i.e., aged 80 years and older as of September
1 2013) who never became eligible.
Our analysis was restricted to adults born between September 1 1925 (88 years old on the start date of the HZ vaccination pro-
gram) and September 1 1942 (71 years old on the start date of the HZ vaccination program). Those born between September 1 1925
and September 1 1933 were never eligible for HZ vaccination, whereas those born between September 2 1933 and September 1
1942 became eligible as part of the catch-up cohort mentioned above. Specifically, the vaccine was offered to those born between:
September 2 1933 and September 1 1934 in the first year of the program (September 1 2013 to August 31 2014); September 2 1934
and September 1 1936 in the second year (September 1 2014 to August 31 2015); September 2 1936 and September 1 1937 in the
third year (September 1 2015 to August 31 2016); and September 2 1937 and September 1 1938 in the fourth year (September 1 2016
to August 31 2017). As of April 1 2017, individuals became eligible for the vaccine on their 78
th
birthday and remained eligible until their
80
th
birthday.
Data source and sample size
This study used the Secure Anonymised Information Linkage (SAIL) Databank.
38,85
This databank provides detailed electronic health
record data from primary care in the NHS through the Welsh Longitudinal General Practice dataset,
39
which contains data on diag-
noses, clinical signs and observations, symptoms, laboratory tests and results, procedures performed (including vaccinations), pre-
scribed medications, and administrative items.
86
Using individuals’ unique NHS number, SAIL links this primary care dataset to
a series of databases. For our study, these databases consisted of the Welsh Demographic Service Dataset,
87
the Patient
Episode Database for Wales (containing hospital-based inpatient care data),
88
the Outpatient Database for Wales (containing
REAGENT or RESOURCE SOURCE IDENTIFIER
Deposited data
Welsh Demographic Service Dataset
(WDSD)
SAIL databank ID: 1306
Welsh Longitudinal General Practice
dataset (WLGP)
SAIL databank ID: 1306
Patient Episode Database for Wales
(PEDW)
SAIL databank ID: 1306
Outpatient Database for Wales (OPDW) SAIL databank ID: 1306
Annual District Death Extract (ADDE) SAIL databank ID: 1306
Welsh Cancer Intelligence and Surveillance
Unit (WCISU)
SAIL databank ID: 1306
Software and algorithms
R 4.3.3 R Core Team http://r-project.org/
Omnissa Horizon Client 2503 Omnissa https://www.omnissa.com/products/
horizon-8/
DB2 11.1 IBM https://www.ibm.com/products/db2
ll
OPEN ACCESS
Cell 188, 1–16.e1–e6, December 11, 2025 e1
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
specialist-based ambulatory care data),
89
the Welsh Cancer Intelligence and Surveillance Unit (containing data on care for cancer),
90
and the Annual District Death Extract (containing cause-of-death data).
91
Our data included individuals’ date of birth in weeks (with
weeks starting on a Monday). A description of each dataset, including the years covered by the data, is provided in Table 2.
We restricted our dataset to all individuals born between September 1 1925 and September 1 1942 who were ever registered with a
primary care provider in the Welsh Longitudinal General Practice Dataset and who were alive and residing in Wales as of the start date
of the HZ vaccination program (September 1 2013). The resulting sample size was 304,940 individuals, of whom 167,461 were re-
corded as female, 137,478 as male, and 1 as ‘unspecified’ gender.
METHOD DETAILS
Study cohorts and follow-up period
Given that each patient in our dataset had a unique anonymized NHS number, we were able to follow patients over time even if they
changed primary care provider. We defined one study cohort for each of our two aims. For determining the effect of HZ vaccination on
the incidence of MCI, we excluded patients whose electronic health record data suggested any cognitive impairment at any time prior
to the start date of the HZ vaccination program. To do so, we used the code list for cognitive impairment published by Moran et al.
(also shown in Data S1),
97
which consists of detailed Read codes for any symptoms, signs, and diagnoses relating to cognitive
impairment, such as disturbances of memory, orientation, concentration, or reasoning, as well as formal diagnoses of MCI and de-
mentia. For determining the effect of HZ vaccination on the occurrence of deaths due to dementia, we restricted our analysis cohort
to those patients with a diagnosis of dementia made at any time prior to the start date of the HZ vaccination program. This cohort is
henceforth referred to as patients living with dementia at baseline. The Read and ICD codes used to define dementia (as well as all
other diagnoses used in this study) are provided in Data S1.
The follow-up period for all primary analyses was nine years, starting on September 1 2013 (the start date of the HZ vaccination
program) and ending on August 31 2022. In secondary analyses, we show all results when using follow-up periods from one to nine
years in one-year increments.
Exposure and outcome definition
The exposure was eligibility for HZ vaccination based on one’s date of birth. As shown in Figure S10, most eligible patients (especially
in the first two eligibility cohorts of the phased rollout, which are the focus of our analysis) in each of our two study populations took up
HZ vaccination during their first year of eligibility.
For determining the effect of HZ vaccination on MCI, our primary outcome was MCI as defined by a record of a Read code (see
Data S1) for MCI in our electronic health record data. As robustness check, we required that the first diagnosis of MCI not be followed
by a new dementia diagnosis within three and within six months to examine the sensitivity of our findings to the possibility of a patient
with mild-to-moderate dementia being falsely classified as having MCI. For determining the effect of HZ vaccination on deaths due to
dementia, our primary outcome was defined as dementia being named as the underlying (i.e., primary) cause of death in the patient’s
death certificate (see Data S1 for ICD-10 codes used). We defined dementia as dementia of any type because of our reduced sta-
tistical power when studying less common outcomes, as well as the neuropathological overlap between dementia types and difficulty
in distinguishing dementia types clinically.
98–100
Dates of deaths were for the date of death registration as opposed to occurrence,
whereby the median delay between death occurrence and registration in Wales in the years from 2001 to 2021 was five days.
96
We used all-cause mortality among patients living with dementia at baseline as a secondary outcome. The rationale for analyzing
this secondary outcome was that if HZ vaccination reduced deaths due to dementia, it will be important to ascertain whether this
effect led to an increase in remaining life expectancy (in which case we would also observe a reduction in all-cause mortality) or
merely to the replacement of dementia as the underlying cause of death on the death certificate with the mentioning of another cause
(in which case we would observe no effect on all-cause mortality). The Read and ICD codes used to define all our outcomes, including
those used as baseline balance checks and in negative control outcome analyses, as well as HZ vaccination are provided in Data S1.
Exploratory outcomes in our analyses were diagnoses of dementia by type. In these analyses, we concentrated on women
because our heterogeneous treatment effect analyses indicated that the observed protective effects of HZ vaccination were predom-
inantly driven by this group. We restricted our comparisons to the three most common dementia types in our dataset (Alzheimer’s
disease, vascular dementia, and mixed dementia) to avoid overly small sample sizes. We only considered diagnoses made in hos-
pital-based rather than primary care. Hospital-based assessments are more likely to involve comprehensive evaluations, including
brain imaging,
47
thereby likely increasing diagnostic accuracy. Because dementia types differ substantially in incidence, we
compared relative rather than absolute effects. Estimating relative effects within a regression discontinuity framework, however, pre-
sents methodological constraints, as there is no established approach for calculating confidence intervals or p-values for these es-
timates.
42
We therefore report point estimates only. We examined the effect of both HZ vaccination eligibility and receipt on dementia
diagnoses by type in two cohorts: i) women without a dementia diagnosis at baseline (i.e., the same cohort as used in Eyting et al.
24
);
and ii) women without any record of cognitive impairment at baseline (i.e., the same cohort used for our MCI outcome analysis). We
also conducted an analysis focusing on dementia diagnoses that occurred after an MCI diagnosis during the follow-up period. For
this analysis, we considered dementia diagnoses made in any care setting to maintain more adequate sample sizes.
ll
OPEN ACCESS
e2 Cell 188, 1–16.e1–e6, December 11, 2025
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
Ethics
Approval was granted by the Information Governance Review Panel (IGRP, application number: 1306), which oversees and approves
applications to use the SAIL databank. This research was also approved by the Stanford University Institutional Review Board on
June 9 2023 and considered minimal risk (protocol number: 70277).
QUANTIFICATION AND STATISTICAL ANALYSIS
The two authors who analyzed the data (M.E. and M.X.) conducted all parts of the analysis independently, compared their results,
and, in the case of any discrepancies, agreed on the preferred coding approach through discussion.
Regression discontinuity analysis
Patients born immediately before versus immediately after September 2 1933 would be expected to be exchangeable (i.e., similar in
observable and unobservable characteristics) with each other except for their probability of receiving HZ vaccination (as a result of
their eligibility status for HZ vaccination). Our analysis approach was guided by this expectation.
Regression discontinuity (RD) is a well-established method for causal effect estimation for such threshold-based exposure assign-
ments.
43
This technique estimates the outcome probability for individuals just on either side of the September 2 1993 date-of-birth
eligibility threshold. As per recommended practice for RD,
41,42,82
we used a mean squared error (MSE)-optimal bandwidth with
robust bias-corrected standard errors,
101
and assigned a higher weight to observations closer to either side of the September 2
1933 date-of-birth eligibility threshold using triangular kernel weights. The MSE-optimal bandwidth was calculated separately for
each combination of study cohort and outcome definition. We used local linear regression because it is the recommended and
most reliable approach for RD analyses even when the relationship between date of birth and the outcome in the entire dataset is
exponential.
102
However, in robustness checks, we also analyzed our data using local quadratic instead of linear regression. Higher
polynomial regressions are not recommended for RD.
102
In addition, we verified that our results were not dependent on the choice of
i) bandwidth (by using bandwidth choices of 0.50, 0.75, 1.25, 1.50, 1.75, and 2.00 times the MSE-optimal bandwidth), and ii) grace
period (i.e., the time since the index date after which follow-up time is considered to begin to allow for the time needed for a full im-
mune response to develop after vaccine administration). In an additional robustness check, we adjusted the follow-up period to ac-
count for the staggered rollout of the HZ vaccination program. Thus, instead of starting the follow-up period for all individuals on
September 1 2013, we started the follow-up period for each individual on the date on which they first became eligible for HZ vacci-
nation. We added cohort fixed effects in these analyses to control for the one- to two-year (depending on the program year) differ-
ences between eligibility cohorts in the start of their follow-up period.
For all outcomes, we estimated both the effect of being eligible for HZ vaccination based on one’s date of birth (the intent-to-treat
[ITT] effect), as well as the effect of actually receiving HZ vaccination (the complier average causal effect [CACE]). To estimate the
CACE, we followed standard practice for RD by implementing a so-called fuzzy RD.
82
While still comparing individuals just on either
side of the date-of-birth eligibility threshold, fuzzy RD corrects the effect estimates for the fact that a proportion of eligible individuals
did not receive the vaccine and a small proportion of ineligible individuals did receive the vaccine. Fuzzy RD is implemented by using
an instrumental variable approach.
82
In our analysis, the instrumental variable was a binary indicator for whether or not an individual
was eligible for HZ vaccination (i.e., born on or after versus born before September 2 1933). This analysis, therefore, adjusted the
effect size of being eligible for HZ vaccination for the magnitude of the abrupt change in the probability of receiving HZ vaccination
at the September 2 1933 threshold. Importantly, fuzzy RD does not compare eligible vaccine recipients with eligible vaccine non-re-
cipients because these groups likely have different health characteristics and behaviors (and, thus, confounding is likely).
Given its implementation using local linear regression, RD yields absolute as opposed to relative effect estimates. All regression
equations used in our analyses are shown in the last section of the STAR Methods.
Testing for confounding
The key advantage of our quasi-randomization approach is that a confounding variable can only bias our analysis if the variable
changes abruptly at the September 2 1933 date-of-birth threshold.
41,42
Thus, confounding bias is unlikely unless another intervention
existed that used the identical date-of-birth eligibility threshold (i.e., September 2 1933) as the HZ vaccination program. We inves-
tigated whether such a competing intervention was likely to exist in four ways.
First, if another intervention that used the identical date-of-birth eligibility threshold had been implemented prior to the HZ vacci-
nation program, then we may expect to observe differences in patients’ health characteristics or past uptake of preventive health
services at the time of the start date of the HZ vaccination program. We, therefore, tested for differences (using the same RD
approach as we used for our primary outcomes) across the September 2 1933 date-of-birth threshold in the prevalence of i) diag-
noses made at any time prior to September 1 2013 for each of the ten most common causes of disability-adjusted life years
(DALYs) and mortality among the age group 70+ years in Wales,
44
and ii) indicators of past preventive health services uptake. The
indicators of past preventive health services uptake available in our data were influenza vaccine receipt in the 12 months preceding
program start, receipt of the pneumococcal vaccine as an adult, current statin use (defined as a new or repeat prescription of a statin
in the 12 months preceding program start), current use of an antihypertensive medication (defined as a new or repeat prescription of
an antihypertensive drug in the 12 months preceding program start), and breast cancer screening participation (defined as the
ll
OPEN ACCESS
Cell 188, 1–16.e1–e6, December 11, 2025 e3
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
proportion of women with a record of referral to, attendance at, or a report from ‘breast cancer screening’ or mammography at any
time prior to the start date of the HZ vaccination program). The codes used to define each of these variables is provided in Data S1.
Second, if a dementia-specific intervention that used the identical date-of-birth eligibility threshold had been implemented before
the HZ vaccination program, then we may expect to observe differences in the incidence of our outcomes across the September 2
1933 threshold prior to the start date of the HZ vaccination program. We, thus, conducted the identical analysis as for our primary
outcomes except for starting the follow-up period nine years prior to the start date (September 1 2013) of the HZ vaccination
program.
Third, if an annual intervention used September 2 as a date-of-birth eligibility criterion, then we may expect to observe significant
differences in our outcomes at the September 2 date-of-birth threshold for birth years other than 1933. We, thus, implemented the
same analyses as we did for the September 2 1933 threshold for the September 2 threshold of each of the three years of birth pre-
ceding and succeeding 1933 (i.e., date-of-birth thresholds of September 2 1930, September 2 1931, September 2 1932, September 2
1934, September 2 1935, and September 2 1936). To ensure that our analyses at these additional date-of-birth thresholds compared
individuals of the same age range as in our primary analyses, we shifted the start and end date of the follow-up period to the same
extent as the date-of-birth threshold. To maintain the same follow-up period in all comparisons, we, therefore, had to use a follow-up
period of six as opposed to nine years. As an example, when comparing individuals across the September 2 1930 threshold, we
started the follow-up period on September 1 2010 and ended the follow-up period on August 31 2016.
Fourth, unless another intervention that used the identical date-of-birth eligibility threshold was specifically designed to affect MCI
and dementia only, we may expect to see an effect of such an intervention on health outcomes other than MCI, dementia, and deaths
due to dementia. We, thus, conducted the same analysis as for our primary outcomes but for diagnoses of, and deaths due to, each of
the ten leading causes of DALYs and mortality in Wales for the age group 70+ years,
44
as well as indicators of preventive health ser-
vices uptake available in our data. The indicators of preventive health services uptake were breast cancer screening among women
(defined as a record of referral to, attendance at, or a report from ‘breast cancer screening’ or mammography at any time after the
start date of the HZ vaccination program), and, for the 12 months after the start of the HZ vaccination program, uptake of influenza
vaccination as well as any prescription of a statin or antihypertensive medication. Among patients without a record of cognitive
impairment prior to the start date of the HZ vaccination program, a new diagnosis of a given condition was defined as the diagnosis
being recorded for the first time in our electronic health record data or as an underlying or contributing cause on the death certificate.
Among patients with a diagnosis of dementia made prior to the start date of the HZ vaccination program, a death was considered to
be caused by a given condition if it was recorded as the underlying cause of death on the death certificate.
Testing for ascertainment bias
If healthcare seeking for episodes of shingles constituted an important opportunity for the health system to identify previously undi-
agnosed MCI, then our analysis for the effect of HZ vaccination on MCI could suffer from ascertainment bias. We conducted three
robustness checks to investigate whether this potential ascertainment bias was likely to represent an important source of bias in this
study. First, if shingles episodes were an important opportunity for the health system to detect previously undiagnosed chronic con-
ditions, then we may expect to observe an effect of HZ vaccination not only on MCI but also on other common chronic conditions. As
described in the preceding section, we, therefore, implemented the same RD analysis as for MCI but for each of the ten leading
causes of DALYs and mortality in Wales in 2019 for the age group 70+ years as outcomes.
44
Second, if healthcare utilization for shin-
gles had an important bearing on the health system’s ability to diagnose MCI, then we may expect that controlling for indicators of
healthcare utilization during the follow-up period would attenuate our effect estimates. We, therefore, adjusted our regressions for the
number of primary care visits, outpatient visits, hospital admissions, and influenza vaccinations received during our nine-year follow-
up period. Third, patients who frequently visit their primary care provider may be more likely to be (whether formally or informally)
screened for MCI. An analysis in this cohort of patients should, therefore, be less susceptible to ascertainment bias. We, thus,
also implemented our analysis when restricting our study population to the sample of those 135,712 (48.0% of the analysis cohort
for our primary analyses for MCI) patients who had made at least one visit to their primary care provider during each of the five years
preceding the start of the HZ vaccination program.
Evidence triangulation
We used a second quasi-experimental approach, namely a difference-in-differences (DID) analysis, to further investigate the robust-
ness of our RD findings. After restricting our sample to patients born between March 1 1926 and February 28 1934, we implemented
our DID approach by dividing our sample into yearly birth cohorts centered around September 1. We then divided each yearly birth
cohort into a pre-September birth ‘season’ and a post-September birth season. The pre-September birth season was, thus, defined
as the six-months period of March 1 to August 31 and the post-September birth season as the six-months period from September 1
to February 28 of the succeeding year. Our DID model tested whether the difference in outcomes across birth seasons was different
for the 1933/1934 birth cohort compared to other yearly birth cohorts. The rationale for our DID was that HZ vaccination eligibility only
differed between the two birth seasons in the 1933/1934-cohort but not in other yearly birth cohorts. The DID approach naturally ad-
justs for any potential systematic differences between pre-September and post-September birth seasons. The regression equations
for this DID approach are detailed in the last section of the STAR Methods.
ll
OPEN ACCESS
e4 Cell 188, 1–16.e1–e6, December 11, 2025
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
Importantly, our DID did not rely on the continuity assumption (i.e., the assumption that potential confounding variables do not
abruptly change at exactly the September 2 1933 date-of-birth eligibility threshold) made by RD. Instead, our DID relied on the
assumption that had the HZ vaccination program not existed, then the difference in our outcomes between the pre- and post-
September birth seasons would have been the same in the 1933/1934-cohort as in other yearly cohorts. A strength of our approach
is that we were able to investigate whether this assumption was likely to be met by testing whether there were significant between-
birth-season differences in our outcomes in cohorts other than the 1933/1934-cohort. We did identify such significant differences for
MCI among patients without a record of cognitive impairment at baseline, but not for deaths due to dementia among patients living
with dementia at baseline. Details are provided in Figure S11. We, therefore, used the DID approach only when analyzing the effect of
HZ vaccination on deaths due to dementia.
Effect heterogeneity analyses
In our previous analysis for the effect of HZ vaccination on new diagnoses of dementia,
57
we found a stronger effect among women
than men. We, therefore, tested for an effect heterogeneity by gender in both of our aims. To do so, in addition to analyzing the effect
among women and men separately, we implemented an interaction model that estimated the difference in effects by gender (the
regression equations for this analysis are provided in the last section of the STAR Methods).
We additionally conducted a set of subgroup analyses that aimed to provide suggestive evidence on whether the protective effect
for deaths due to dementia also exists among those already living with more advanced dementia at the time of the start date of the HZ
vaccination program. We used five measures, all of which were measured during the time period prior to September 1 2013, that we
hypothesized are likely correlated with the degree of dementia severity: i) the total number of inpatient days spent in hospital as part of
admissions for which dementia was recorded as the principal or secondary reason; ii) the number of hospital admissions for which
dementia was recorded as the principal or secondary diagnosis; iii) the number of times that a diagnosis of dementia was recorded in
our electronic health record data (regardless of whether the diagnosis was recorded in primary, secondary, or tertiary care); iv) the
predicted probability of dying due to dementia (i.e., a death with dementia recorded as the underlying cause on the death certificate)
during the follow-up period; and v) the predicted probability of dying from any cause during the follow-up period. We calculated the
predicted probability of death from any cause using a logistic regression model with death from any cause during the nine-year
follow-up period as outcome and age on September 1 2013 as well as each condition (as measured in the time period prior to
September 1 2013) that is part of the Charlson Comorbidity Index (except for AIDS, which is a condition that is suppressed in the
SAIL database for privacy reasons) as predictor variables.
46
The coefficients were first estimated using only patients who were inel-
igible for HZ vaccination based on their date of birth. The estimated model was then used to predict the risk of death for all patients
whilst imputing a fixed age of 80 years. The predicted probability of deaths due to dementia was calculated using the same approach
except that we also included the total number of inpatient days spent in hospital (as part of admissions for which dementia was re-
corded as the principal or secondary reason) and the number of recordings of a diagnosis of dementia as additional predictors. To
maximize statistical power for detecting subgroup differences, we defined subgroups for each dementia severity measure based on
whether individuals were above or below the median. When using our regression discontinuity approach, we compared both the ab-
solute and relative effects of HZ vaccination on deaths due to dementia between these subgroups. The relative effects were esti-
mated by dividing the absolute effect by the predicted value of the outcome just left (i.e., among those who were ineligible for HZ
vaccination when analyzing the effect of vaccination eligibility and among those who were ineligible for HZ vaccination and complied
with their eligibility assignment when analyzing the effect of vaccine receipt) of the September 2 1933 date-of-birth eligibility
threshold. The confidence intervals and p-values for these relative effect estimates were calculated using the delta method.
Regression equations
Regression discontinuity
We used the following model to estimate the effect of being eligible for HZ vaccination on our outcomes:
Y
i
= α + β
1
D
i
+ β
2
(WOB
i
c
o
) + β
3
D
i
(WOB
i
c
0
) + ϵ
i
; (Equation 1)
where Y
i
was a dichotomous variable indicating if an individual had the outcome, and D
i
was a dichotomous variable indicating eligi-
bility for HZ vaccination (i.e., D
i
was equal to one if an individual was born on or after September 2 1933). The term (WOB
i
c
0
) and
the interaction term D
i
(WOB
i
c
0
) adjusted for how many weeks away from the September 2 1933 date-of-birth eligibility threshold
an individual was born. These terms fitted two regression lines on either side of the September 2 1933 date-of-birth eligibility
threshold whereby the slope of these regression lines could differ on either side of the threshold. The coefficient β
1
identified the effect
of being eligible for HZ vaccination on the outcome.
We used the following model to estimate the effect of receiving HZ vaccination on our outcomes:
Y
i
= θ + γ
1
̂
V
i
+ γ
2
(WOB
i
c
o
) + γ
3
D
i
(WOB
i
c
0
) + ε
i
; (Equation 2)
where V
i
was a dichotomous variable indicating if an individual received HZ vaccination and was instrumented by D
i
.
̂
V
i
was the pre-
dicted probability of receiving HZ vaccination based on the estimation of Equation 1 with V
i
as the left-hand-side variable. γ
1
was the
effect of receiving HZ vaccination. θ was the constant and ε
i
an error term. All other variables were the same as in regression Equation
ll
OPEN ACCESS
Cell 188, 1–16.e1–e6, December 11, 2025 e5
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
1. Equation 2, thus, implemented a so-called fuzzy regression discontinuity (RD) design,
82
which adjusted the effect size for being
eligible for HZ vaccination by the size of the abrupt change in the probability of receiving HZ vaccination at the September 2 1933
date-of-birth eligibility threshold. As is common practice for fuzzy RD,
82
our fuzzy RD achieved this adjustment by using a dichoto-
mous variable that indicated whether or not an individual was eligible to receive HZ vaccination as an instrumental variable for actual
receipt of HZ vaccination. For Equations 1 and 2, we restricted the analysis to individuals who were born within the MSE-optimal
bandwidths around the threshold, applied triangular kernel weights, and reported p-values and 95% confidence intervals based
on robust bias-corrected standard errors.
101
Difference-in-differences
As described in the STAR Methods section in the main manuscript, we implemented our DID approach by dividing our sample into
yearly birth cohorts centered around September 1, and then dividing each yearly birth cohort into a pre-September birth ‘season’
(i.e., the six-months period of March 1 to August 31) and a post-September birth season (i.e., the six-months period from September
1 to February 28 of the succeeding year). Our DID approach relied on the assumption that in the absence of the date of birth-based
eligibility rule for HZ vaccination, the between-birth-season difference in the outcome would have been the same in the 1933/1934-
cohort as in the other yearly birth cohorts. To investigate the validity of this assumption, we estimated the between-birth-season dif-
ference in the outcome for each yearly birth cohort, whereby the difference in the 1932/33-cohort served as the reference group.
Specifically, we used the following model:
Y
i
= θ +
h=1932
(
γ
h
S
i
C
i
h
)
+ η
m
+ η
c
+ ϵ
i
; (Equation 3)
where Y
i
was the outcome of patient i, and S
i
a dichotomous variable indicating that patient i was born in the post-September birth
season. C
i
h
indicated whether patient i belonged to birth cohort h, with h = 1926/27, 1927/28, , 1931/32, and 1933/34. γ
h
identified
the between-birth-season difference of the yearly birth cohort h relative to the 1932/33-cohort. θ was the constant term, η
m
and η
c
indicated the birth month and birth cohort fixed-effect, respectively. ϵ
i
was the error term. Figure S11 plots the estimates of γ
h
with
95% confidence intervals by yearly birth cohort.
We used a two-stage least squares procedure to implement our DID approach. The first stage estimated the change in the prob-
ability of receiving HZ vaccination due to the date of birth-based eligibility rule. We used the following model:
V
i
= θ + γS
i
C
i
+ η
m
+ η
c
+ ϵ
i
; (Equation 4)
where V
i
was a dichotomous variable indicating whether patient i had received HZ vaccination, S
i
a dichotomous variable indicating
that patient i was born in the post-September birth season, and C
i
a dichotomous variable indicating that patient i was in the 1933/
1934 birth cohort. γ identified the change in the probability of receiving HZ vaccination as a result of the date of birth-based eligibility
rule. θ was a constant term and ϵ
i
was the error term. η
m
and η
c
were the birth month and cohort fixed effect, respectively.
In the second stage, we estimated the effect of receipt of HZ vaccination on our outcomes. We used the following model:
Y
i
= α + β
̂
V
i
+ η
m
+ η
c
+ ε
i
; (Equation 5)
where Y
i
was the outcome of patient i, and
̂
V
i
was the probability of receiving HZ vaccination as a result of the date of birth-based
eligibility rule as estimated from the first-stage regression (4). The coefficient β identified the effect of HZ vaccination receipt on our
outcome. θ; η
m
, and η
c
were the constant term, birth month, and yearly birth cohort (1926/1927, 1927/1928, , 1933/1934) fixed ef-
fect, respectively. ε
i
was the error term.
Heterogeneous treatment effect by gender
The difference in CACE by gender was estimated by running the following instrumental variable model:
Y
i
= α + β
1
V
i
+ β
2
(WOB
i
c
0
) + β
3
D
i
(WOB
i
c
0
) + β
4
V
i
MALE
i
+ β
5
(WOB
i
c
0
) MALE
i
+ β
6
D
i
(WOB
i
c
0
) MALE
i
+ β
7
MALE
i
+ϵ
i
(Equation 6)
where Y
i
, D
i
, (WOB
i
c
0
) and V
i
adopted the same definitions as in Equations 1 and 2. MALE
i
was a dichotomous variable indicating
if an individual’s gender was male. ϵ
i
was the error term. The coefficient β
4
identifies the gender difference in the effect of receipt of the
vaccine on the outcome. In estimating the coefficients, V
i
and V
i
MALE
i
were instrumented by D
i
and D
i
MALE
i
. In line with our pri-
mary discontinuity models, we applied triangular weights to the regression along with the MSE-optimal bandwidth sizes from the
corresponding specification excluding interaction terms by gender in our primary analyses.
ll
OPEN ACCESS
e6 Cell 188, 1–16.e1–e6, December 11, 2025
Please cite this article in press as: Xie et al., The effect of shingles vaccination at different stages of the dementia disease course, Cell (2025),
https://doi.org/10.1016/j.cell.2025.11.007
Article
Supplemental figures
Indicators of preventive health services uptake
Leading causes of morbidity and mortality
Antihypertensive medication use
Breast cancer screening
Influenza vaccination
PPV vaccination
Statin use
Breast cancer
COPD
Colorectal cancer
Dementia
Diabetes mellitus
Falls
Ischemic heart disease
Lower back pain
Lower respiratory tract infection
Lung cancer
Mild cognitive impairment
Pancreatic cancer
Shingles
Stroke
0.7 ( −1.1, 2.5)
−0.5 ( −2.5, 1.5)
0.0 ( −1.5, 1.4)
−0.1 ( −2.0, 1.3)
0.8 ( −0.7, 2.7)
0.2 ( −0.7, 1.0)
0.0 ( −1.1, 1.3)
0.4 ( −0.1, 1.2)
0.5 ( −0.3, 1.4)
0.0 ( −1.5, 1.5)
0.4 ( −0.9, 2.0)
−0.7 ( −2.2, 0.4)
−0.9 ( −3.0, 0.9)
0.2 ( −1.7, 1.9)
0.1 ( −0.2, 0.3)
−0.2 ( −1.1, 0.4)
0.0 ( −0.1, 0.1)
0.1 ( −1.2, 1.4)
−0.2 ( −1.2, 0.8)
0.455
0.626
0.918
0.696
0.244
0.765
0.933
0.113
0.174
0.999
0.462
0.173
0.299
0.909
0.493
0.390
0.926
0.887
0.645
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−5.0 −2.5 0.0 2.5 5.0
Among patients without cognitive impairment at baseline
Indicators of preventive health services uptake
Leading causes of morbidity and mortality
Antihypertensive medication use
Breast cancer screening
Influenza vaccination
PPV vaccination
Statin use
Breast cancer
COPD
Colorectal cancer
Deaths due to dementia
Diabetes mellitus
Falls
Ischemic heart disease
Lower back pain
Lower respiratory tract infection
Lung cancer
Pancreatic cancer
Stroke
3.2 ( −5.2, 11.8)
6.5 ( −0.8, 16.8)
−0.4 ( −7.8, 7.0)
−1.2 ( −7.3, 4.5)
−1.9 ( −9.8, 5.2)
2.3 ( −0.7, 6.3)
0.4 ( −4.5, 5.1)
−0.3 ( −2.2, 1.8)
−5.2 (−17.7, 6.7)
−0.6 ( −7.2, 6.8)
−3.1 (−10.4, 4.4)
−8.5 (−15.8, −2.4)
1.2 ( −6.8, 10.5)
−4.3 (−12.1, 1.8)
0.5 ( −0.2, 1.3)
0.2 ( −0.1, 0.5)
0.8 ( −4.8, 7.3)
0.447
0.076
0.916
0.633
0.547
0.121
0.888
0.859
0.375
0.960
0.424
0.008
0.680
0.148
0.130
0.173
0.691
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−20 −10 0 10 20
Among patients living with dementia at baseline
Figure S1. Baseline balance checks using diagnoses of the ten most common causes of DALYs and mortality among adults aged 70+ years
in Wales, as well as indicators of preventive health services uptake, related to Figure 1
Baseline refers to the start date of the HZ vaccination program (i.e., September 1, 2013). We used diagnoses of the ten most common causes of disability-
adjusted life years (DALYs) and mortality among the age group 70+ years in Wales, as estimated by the 2019 Global Burden of Disease study.
44
Statin use was
defined as a new or repeat prescription of a statin in the 12 months preceding September 1, 2013. PPV vaccination was defined as receipt of the PPV vaccine as
an adult at any time prior to September 1, 2013. Influenza vaccination was defined as receipt of the influenza vaccine in the 12 months preceding September 1,
2013. Breast cancer screening was defined as the proportion of women with a record of referral to, attendance at, or a report from breast cancer screening or
mammography at any time prior to September 1, 2013. Antihypertensive medication use was defined as a new or repeat prescription of an antihypertensive drug
in the 12 months preceding September 1, 2013. The study cohorts for the baseline balance checks for MCI and dementia did not exclude individuals with any
record of cognitive impairment prior to September 1, 2013. Similarly, the study cohort for the baseline balance check for deaths due to dementia was not
restricted to individuals who were alive on September 1, 2013. For all other baseline balance checks, the study cohort was defined as detailed in the STAR
Methods. Dots show the point estimate and horizontal bars the 95% CI. The codes used to define each condition are listed in Data S1.
Abbreviations are as follows: CI, confidence interval; COPD, chronic obstructive pulmonary disease; PPV, pneumococcal polysaccharide vaccine.
ll
OPEN ACCESS
Article
Follow−up period (years)
11
22
33
44
55
66
77
88
99
−0.1 (−0.6, 0.1)
−0.3 (−1.4, 0.2)
−0.5 (−1.1, −0.1)
−1.3 (−2.8, −0.4)
−0.6 (−1.3, −0.1)
−1.6 (−3.5, −0.5)
−1.1 (−2.1, −0.4)
−2.0 (−4.4, −0.8)
−0.8 (−1.9, 0.0)
−1.6 (−4.1, 0.0)
−0.8 (−2.0, 0.0)
−1.9 (−4.6, −0.2)
−1.2 (−2.4, −0.3)
−2.5 (−5.5, −0.8)
−1.3 (−2.5, −0.4)
−2.8 (−5.8, −0.8)
−1.5 (−2.9, −0.5)
−3.1 (−6.2, −1.0)
0.253
0.157
0.026
0.009
0.025
0.008
0.005
0.005
0.061
0.055
0.041
0.034
0.010
0.009
0.008
0.009
0.006
0.007
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−10.0 −7.5 −5.0 −2.5 0.0 2.5
Effect of vaccination eligibility
Effect of vaccine receipt
Effect on MCI
Follow−up period (years)
11
22
33
44
55
66
77
88
99
−2.6 (−7.1, 1.4)
−8.9 (−24.2, 5.1)
−2.7 (−9.2, 3.7)
−9.4 (−31.3, 13.3)
−3.4 (−10.7, 2.8)
−12.0 (−37.0, 10.1)
−3.9 (−11.3, 3.8)
−13.6 (−38.6, 13.9)
−6.6 (−15.3, 1.9)
−22.8 (−52.1, 7.6)
−8.9 (−19.1, −1.0)
−30.7 (−65.4, −2.1)
−8.2 (−18.5, −0.2)
−28.4 (−63.3, 0.5)
−7.7 (−17.6, 0.2)
−26.7 (−59.9, 2.1)
−8.5 (−18.5, −0.6)
−29.5 (−62.9, −0.6)
0.183
0.200
0.407
0.430
0.249
0.264
0.334
0.356
0.125
0.145
0.029
0.036
0.044
0.054
0.056
0.068
0.036
0.046
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−75 −50 −25 0 25
Effect of vaccination eligibility
Effect of vaccine receipt
Effect on deaths due to dementia
Figure S2. The effect of HZ vaccination eligibility and receipt on our outcomes across different lengths of follow-up, related to Figure 2
Dots or triangles show the point estimate and horizontal bars the 95% CI.
Abbreviations are as follows: MCI, mild cognitive impairment; CI, confidence interval.
ll
OPEN ACCESS
Article
Other checks
Alternative outcome definition
Grace−period (months)
Bandwidth choice (as x−times the MSE−optimal bandwidth)
Accounting for staggered roll−outAccounting for staggered roll−out
Controlling for health service utilizationControlling for health service utilization
Quadratic fitQuadratic fit
Restricting to frequent GP visitorsRestricting to frequent GP visitors
MCI not followed by dementia within 3 monthsMCI not followed by dementia within 3 months
MCI not followed by dementia within 6 monthsMCI not followed by dementia within 6 months
00
22
44
0.50.5
0.750.75
11
1.251.25
1.51.5
1.751.75
2 2
−1.5 ( −2.8, −0.5)
−3.3 ( −6.8, −0.5)
−1.5 ( −2.8, −0.5)
−3.1 ( −6.1, −1.0)
−1.7 ( −3.3, −0.6)
−3.5 ( −6.7, −1.1)
−1.3 ( −2.8, −0.3)
−2.6 ( −5.7, −0.4)
−1.4 ( −2.8, −0.5)
−3.0 ( −5.9, −1.1)
−1.3 ( −2.6, −0.4)
−2.8 ( −5.6, −1.0)
−1.5 ( −2.9, −0.5)
−3.1 ( −6.2, −1.0)
−1.5 ( −2.9, −0.5)
−3.1 ( −6.3, −1.0)
−1.5 ( −3.0, −0.5)
−3.3 ( −6.5, −1.2)
−1.7 ( −3.4, 0.0)
−3.7 ( −8.3, −0.1)
−1.4 ( −2.9, −0.2)
−3.1 ( −6.5, −0.2)
−1.5 ( −2.9, −0.5)
−3.1 ( −6.2, −1.0)
−1.4 ( −2.6, −0.5)
−2.9 ( −5.7, −1.0)
−1.1 ( −2.3, −0.3)
−2.4 ( −4.9, −0.7)
−1.0 ( −2.0, −0.2)
−2.1 ( −4.5, −0.5)
−0.9 ( −1.7, −0.1)
−1.9 ( −4.0, −0.3)
0.005
0.022
0.006
0.006
0.006
0.007
0.017
0.022
0.006
0.005
0.006
0.004
0.006
0.007
0.006
0.007
0.005
0.004
0.056
0.046
0.027
0.036
0.006
0.007
0.005
0.005
0.009
0.011
0.017
0.014
0.033
0.026
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−10.0 −7.5 −5.0 −2.5 0.0 2.5
Effect of v
accination eligibility
Effect of vaccine receipt
Effect on MCI
Other checks
Grace−period (months)
Ban
dwidth choice (as x−times the MSE−optimal bandwidth)
Accounting for staggered roll−outAccounting for staggered roll−out
Adjusting for baseline IHD diagnosisAdjusting for baseline IHD diagnosis
Quadratic fitQuadratic fit
00
22
44
0.50.5
0.750.75
11
1.251.25
1.51.5
1.751.75
2 2
−8.1 ( −18.0, −0.3)
−31.3 ( −69.2, −0.2)
−7.7 ( −13.7, −1.7)
−27.1 ( −48.2, −6.0)
−8.9 ( −19.6, 0.4)
−29.6 ( −64.6, 2.7)
−8.5 ( −18.5, −0.6)
−29.5 ( −62.9, −0.6)
−8.1 ( −17.8, −0.2)
−28.0 ( −60.7, 1.0)
−8.0 ( −17.8, −0.1)
−27.9 ( −60.7, 1.4)
−8.4 ( −21.1, 4.7)
−29.3 ( −73.9, 16.6)
−9.0 ( −20.5, 0.2)
−32.2 ( −73.1, 1.5)
−8.5 ( −18.5, −0.6)
−29.5 ( −62.9, −0.6)
−7.0 ( −15.9, 0.0)
−24.7 ( −55.5, 1.0)
−6.4 ( −14.7, −0.2)
−23.5 ( −54.2, −0.4)
−5.8 ( −13.9, −0.5)
−22.0 ( −53.1, −2.2)
−5.4 ( −12.9, −0.4)
−20.6 ( −50.1, −2.0)
0.042
0.048
0.012
0.012
0.061
0.072
0.036
0.046
0.045
0.058
0.048
0.061
0.212
0.215
0.055
0.060
0.036
0.046
0.051
0.059
0.043
0.047
0.034
0.033
0.036
0.033
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−100 −75 −50 −25 0 25
Effect of vaccination eligibility
Effect of vaccine receipt
Effect on deaths due to dementia
(legend on next page)
ll
OPEN ACCESS
Article
Figure S3. Robustness checks for the effect of HZ vaccination eligibility and receipt on our outcomes, related to Figure 2
Dots or triangles show the point estimate and horizontal bars the 95% CI. With ‘grace periods,’’ we refer to time periods since the index date after which follow-up
time is considered to begin to allow for the time needed for a full immune response to develop after vaccine administration. Frequent GP visitors were defined as
patients who had made at least one visit to their primary care provider during each of the 5 years preceding the start of the HZ vaccination program. The health
service utilization indicators that were used when controlling for health service utilization were the number of primary care visits, outpatient visits, hospital ad-
missions, and influenza vaccinations received during our 9-year follow-up period. As described in detail in the STAR Methods, when accounting for the staggered
roll-out of the program, we adjusted the follow-up period to begin for each individual on the date on which they first became eligible for HZ vaccination (instead of
starting the follow-up period for all individuals on September 1, 2013). We added cohort fixed effects to these analyses to control for between-cohort differences
in the date at which the follow-up window started. That is, we defined one cohort fixed effect for ineligible individuals and the first catch-up cohort and included
additional cohort fixed effects for each group of patients who became eligible at the same time.
Abbreviations are as follows: MCI, mild cognitive impairment; CI, confidence interval; MSE, mean squared error; GP, general practitioner; IHD, ischemic heart
disease.
ll
OPEN ACCESS
Article
Eligibility cutoff with a 6−
Effect size, 95% CI
Effect size, 95% CI
Figure S4. The September 2 date-of-birth threshold only had a significant effect on our outcomes in the birth year (1933) that was used by the
herpes zoster vaccination program as eligibility criterion, related to Figure 2
Diamonds or crosses show the point estimate and horizontal bars the 95% CI. New diagnoses of MCI were analyzed among a study cohort of patients who did not
have any record of cognitive impairment prior to the start of the follow-up period. Deaths due to dementia were analyzed among a study cohort of patients who
had received a diagnosis of dementia prior to the start of the follow-up period. We used a 6-year instead of a 9-year follow-up period in this analysis to allow for the
same length of follow-up for all comparisons.
Abbreviations are as follows: CI, confidence interval; MCI, mild cognitive impairment.
ll
OPEN ACCESS
Article
Other checks
Alternative outcome definition
Grace−period (months)
Ban
dwidth choice (as x−times the MSE−optimal bandwidth)
Accounting for staggered roll−outAccounting for staggered roll−out
Controlling for health service utilizationControlling for health service utilization
Quadratic fitQuadratic fit
Restricting to frequent GP visitorsRestricting to frequent GP visitors
MCI not followed by dementia within 3 monthsMCI not followed by dementia within 3 months
MCI not followed by dementia within 6 monthsMCI not followed by dementia within 6 months
00
22
44
0.50.5
0.750.75
11
1.251.25
1.51.5
1.751.75
2 2
−2.4 ( −4.4, −1.1)
−5.4 (−10.3, −2.5)
−2.4 ( −4.3, −1.2)
−5.1 ( −9.7, −2.6)
−2.8 ( −4.8, −1.2)
−6.1 (−10.6, −2.5)
−2.4 ( −4.5, −0.9)
−4.3 ( −9.0, −1.8)
−2.5 ( −4.5, −1.2)
−5.1 ( −9.6, −2.8)
−2.4 ( −4.2, −1.1)
−4.8 ( −9.1, −2.6)
−2.5 ( −4.5, −1.1)
−5.1 ( −9.8, −2.6)
−2.4 ( −4.4, −1.0)
−4.9 ( −9.6, −2.3)
−2.5 ( −4.6, −1.1)
−5.3 (−10.1, −2.7)
−2.7 ( −5.2, −0.3)
−5.9 (−11.9, −1.0)
−2.6 ( −4.8, −0.9)
−5.6 (−10.7, −2.3)
−2.5 ( −4.5, −1.1)
−5.1 ( −9.8, −2.6)
−2.3 ( −4.1, −1.1)
−4.3 ( −8.8, −2.3)
−2.0 ( −3.7, −1.0)
−3.6 ( −8.0, −2.0)
−1.7 ( −3.3, −0.8)
−3.1 ( −7.1, −1.5)
−1.5 ( −2.9, −0.5)
−2.5 ( −6.1, −0.9)
0.001
0.001
<0.001
<0.001
0.001
0.001
0.004
0.004
<0.001
<0.001
<0.001
<0.001
0.001
<0.001
0.002
0.001
0.001
<0.001
0.026
0.021
0.004
0.003
0.001
<0.001
<0.001
<0.001
<0.001
0.001
0.002
0.003
0.004
0.008
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−15 −10 −5 0 5
Effect of vaccination eligibility
Effect of vaccine receipt
Effect on MCI among women
Other checks
Grace−period (months)
Ban
dwidth choice (as x−times the MSE−optimal bandwidth)
Accounting for staggered roll−outAccounting for staggered roll−out
Adjusting for baseline IHD diagnosisAdjusting for baseline IHD diagnosis
Quadratic fitQuadratic fit
00
22
44
0.50.5
0.750.75
11
1.251.25
1.51.5
1.751.75
2 2
−12.7 ( −24.8, −2.3)
−51.7 (−100.5, −6.1)
−14.4 ( −23.7, −5.1)
−60.7 ( −98.8, −22.6)
−14.0 ( −27.5, −1.8)
−50.5 ( −98.6, −3.4)
−13.9 ( −26.3, −3.4)
−52.3 ( −97.9, −9.2)
−14.5 ( −26.7, −4.2)
−55.0 (−100.3, −11.5)
−13.7 ( −25.7, −3.4)
−52.0 ( −96.7, −8.7)
−14.2 ( −30.2, 2.8)
−52.3 (−111.9, 13.1)
−15.2 ( −30.4, −3.8)
−57.9 (−117.0, −11.7)
−13.9 ( −26.3, −3.4)
−52.3 ( −97.9, −9.2)
−11.8 ( −22.8, −2.5)
−45.5 ( −86.7, −7.0)
−11.6 ( −22.2, −3.8)
−46.5 ( −89.0, −13.1)
−11.3 ( −21.5, −4.5)
−46.4 ( −88.7, −17.1)
−10.9 ( −20.2, −4.3)
−45.4 ( −85.0, −17.0)
0.018
0.027
0.002
0.002
0.026
0.036
0.011
0.018
0.007
0.014
0.010
0.019
0.103
0.121
0.012
0.017
0.011
0.018
0.015
0.021
0.006
0.008
0.003
0.004
0.002
0.003
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−120 −80 −40 0
Effect of vaccination eligibility
Effect of vaccine receipt
Effect on deaths due to dementia among women
(legend on next page)
ll
OPEN ACCESS
Article
Figure S5. Robustness checks for the effect of HZ vaccination eligibility and receipt on our outcomes among women only, related to Figure 4
Dots or triangles show the point estimate and horizontal bars the 95% CI. With grace periods, we refer to time periods since the index date after which follow-up
time is considered to begin to allow for the time needed for a full immune response to develop after vaccine administration. Frequent GP visitors were defined as
patients who had made at least one visit to their primary care provider during each of the 5 years preceding the start of the HZ vaccination program. The health
service utilization indicators that were used when controlling for health service utilization were the number of primary care visits, outpatient visits, hospital ad-
missions, and influenza vaccinations received during our 9-year follow-up period. As described in detail in the STAR Methods, when accounting for the staggered
roll-out of the program, we adjusted the follow-up period to begin for each individual on the date on which they first became eligible for HZ vaccination (instead of
starting the follow-up period for all individuals on September 1, 2013). We added cohort fixed effects to these analyses to control for between-cohort differences
in the date at which the follow-up window started. That is, we defined one cohort fixed effect for ineligible individuals and the first catch-up cohort and included
additional cohort fixed effects for each group of patients who became eligible at the same time.
Abbreviations are as follows: MCI, mild cognitive impairment; CI, confidence interval; MSE, mean squared error; GP, general practitioner; IHD, ischemic heart
disease.
ll
OPEN ACCESS
Article
Number of recordings of dementia
Number of dementia−related
hospital admissions
Length of dementia−related
hospital stay
Predicted risk of
all−cause mortality
Predicted risk of
death due to dementia
Dementia severity measure
Effect of vaccine receipt Effect of vaccine receipt
Effect of vaccination eligibility Effect of vaccination eligibility
Effect of vaccine receipt Effect of vaccine receipt
Effect of vaccination eligibility Effect of vaccination eligibility
Effect of vaccine receipt Effect of vaccine receipt
Effect of vaccination eligibility Effect of vaccination eligibility
Effect of vaccine receipt Effect of vaccine receipt
Effect of vaccination eligibility Effect of vaccination eligibility
Effect of vaccine receipt Effect of vaccine receipt
Effect of vaccination eligibility Effect of vaccination eligibility
1478
2292
1478
2292
1073
2665
1073
2665
1615
2131
1615
2131
1587
2306
1587
2306
1706
2008
1706
2008
−8.3 ( −23.3, 4.1)
−7.1 ( −19.4, 2.8)
−33.7 ( −92.0, 19.3)
−23.0 ( −61.9, 10.0)
−6.7 ( −24.6, 9.4)
−7.7 ( −18.8, 1.5)
−50.7 (−189.0, 77.3)
−22.8 ( −55.1, 5.4)
−13.5 ( −28.8, −2.3)
−3.3 ( −14.8, 8.4)
−70.2 (−152.8, −5.6)
−9.1 ( −40.0, 23.3)
−10.1 ( −24.8, 1.6)
−6.7 ( −17.8, 3.9)
−35.6 ( −86.9, 8.1)
−23.2 ( −61.0, 14.5)
−10.0 ( −24.1, 0.8)
−6.2 ( −18.5, 5.1)
−36.0 ( −84.4, 4.1)
−20.7 ( −61.6, 18.8)
0.171
0.141
0.200
0.157
0.378
0.093
0.411
0.108
0.022
0.587
0.035
0.606
0.084
0.212
0.104
0.227
0.067
0.268
0.076
0.296
0.171
0.141
0.200
0.157
0.378
0.093
0.411
0.108
0.022
0.587
0.035
0.606
0.084
0.212
0.104
0.227
0.067
0.268
0.076
0.296
N
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−200 −100 0
Below median
Above median
Number of recordings of dementia
Number of dementia−related
hospital admissions
Length of dementia−related
hospital stay
Predicted risk of
all−cause mortality
Predicted risk of
death due to dementia
Dementia severity measure
Effect of vaccine receipt Effect of vaccine receipt
Effect of vaccination eligibility Effect of vaccination eligibility
Effect of vaccine receipt Effect of vaccine receipt
Effect of vaccination eligibility Effect of vaccination eligibility
Effect of vaccine receipt Effect of vaccine receipt
Effect of vaccination eligibility Effect of vaccination eligibility
Effect of vaccine receipt Effect of vaccine receipt
Effect of vaccination eligibility Effect of vaccination eligibility
Effect of vaccine receipt Effect of vaccine receipt
Effect of vaccination eligibility Effect of vaccination eligibility
1478
2292
1478
2292
1073
2665
1073
2665
1615
2131
1615
2131
1587
2306
1587
2306
1706
2008
1706
2008
−13.6 ( −30.8, 3.6)
−14.6 ( −32.1, 2.9)
−41.7 ( −79.0, −4.5)
−35.8 ( −68.8, −2.8)
−11.6 ( −34.2, 11.0)
−14.6 ( −29.6, 0.4)
−49.6 (−107.7, 8.4)
−35.2 ( −63.3, −7.1)
−22.3 ( −38.7, −5.8)
−6.9 ( −25.7, 12.0)
−58.7 ( −84.6, −32.8)
−18.4 ( −62.9, 26.1)
−18.5 ( −37.2, 0.2)
−12.2 ( −27.8, 3.4)
−49.1 ( −82.8, −15.4)
−33.3 ( −66.3, −0.3)
−16.7 ( −33.0, −0.5)
−12.9 ( −32.0, 6.1)
−48.8 ( −79.7, −17.9)
−30.6 ( −67.2, 6.1)
0.122
0.102
0.028
0.033
0.314
0.057
0.094
0.014
0.008
0.475
0.000
0.418
0.053
0.126
0.004
0.048
0.044
0.184
0.002
0.102
0.122
0.102
0.028
0.033
0.314
0.057
0.094
0.014
0.008
0.475
0.000
0.418
0.053
0.126
0.004
0.048
0.044
0.184
0.002
0.102
N
Effect size, 95% CI
(percent)
p
Effect size, 95% CI
(percent)
−80 −40 0
Below median
Above median
Figure S6. The absolute and relative effect of HZ vaccination eligibility and receipt on deaths due to dementia among those above versus
below the median for different surrogate measures of dementia severity using regression discontinuity, related to Figure 4
Dots show the point estimate and horizontal bars the 95% CI. The definition and calculation of each dementia severity measure is provided in the STAR Methods.
Each dementia severity measure was assessed during the time period prior to September 1, 2013. p values and CIs for the relative effect estimates were
calculated using the delta method. There is, however, no well-established method for estimating p values and CIs for relative effect estimates in a regression
discontinuity approach.
42
These values should, therefore, be interpreted with caution.
Abbreviation is as follows: CI, confidence interval.
ll
OPEN ACCESS
Article
Number of recordings of dementia
Number of dementia−related
hospital admissions
Length of dementia−related
hospital stay
Predicted risk of
all−cause mortality
Predicted risk of
death due to dementia
Dementia severity measure
Effect of vaccine receipt Effect of vaccine receipt
Effect of vaccination eligibility Effect of vaccination eligibility
Effect of vaccine receipt Effect of vaccine receipt
Effect of vaccination eligibility Effect of vaccination eligibility
Effect of vaccine receipt Effect of vaccine receipt
Effect of vaccination eligibility Effect of vaccination eligibility
Effect of vaccine receipt Effect of vaccine receipt
Effect of vaccination eligibility Effect of vaccination eligibility
Effect of vaccine receipt Effect of vaccine receipt
Effect of vaccination eligibility Effect of vaccination eligibility
3504
5045
3504
5045
2622
5927
2622
5927
4409
4140
4409
4140
4366
4183
4366
4183
4215
4334
4215
4334
−12.8 ( −24.1, −1.5)
−7.2 ( −16.2, 1.8)
−54.4 (−103.7, −5.0)
−26.7 ( −60.1, 6.8)
−10.7 ( −24.5, 3.2)
−7.8 ( −16.0, 0.5)
−94.8 (−227.6, 38.1)
−25.7 ( −53.3, 1.8)
−13.5 ( −23.8, −3.2)
−4.3 ( −14.1, 5.4)
−75.7 (−137.6, −13.7)
−13.4 ( −43.6, 16.7)
−14.5 ( −24.7, −4.4)
−3.3 ( −13.2, 6.6)
−53.1 ( −91.6, −14.7)
−13.7 ( −54.6, 27.2)
−8.3 ( −18.4, 1.9)
−9.6 ( −19.4, 0.3)
−36.1 ( −80.6, 8.3)
−33.5 ( −68.7, 1.6)
0.026
0.117
0.031
0.119
0.131
0.066
0.162
0.067
0.010
0.385
0.017
0.383
0.005
0.511
0.007
0.511
0.112
0.056
0.111
0.061
0.026
0.117
0.031
0.119
0.131
0.066
0.162
0.067
0.010
0.385
0.017
0.383
0.005
0.511
0.007
0.511
0.112
0.056
0.111
0.061
N
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−200 −150 −100 −50 0 50
Below median
Above median
Figure S7. The absolute effect of HZ vaccination eligibility and receipt on deaths due to dementia among those above versus below the
median for different surrogate measures of dementia severity using a difference-in-differences approach, related to Figure 4
Dots show the point estimate and horizontal bars the 95% CI. The definition and calculation of each dementia severity measure is provided in the STAR Methods.
Each dementia severity measure was assessed during the time period prior to September 1, 2013.
Abbreviation is as follows: CI, confidence interval.
ll
OPEN ACCESS
Article
All−cause mortality
Non−dementia deaths
Deaths due to dementia
Effect of vaccination eligibilityEffect of vaccination eligibility
Effect of vaccine receiptEffect of vaccine receipt
Effect of vaccination eligibilityEffect of vaccination eligibility
Effect of vaccine receiptEffect of vaccine receipt
Effect of vaccination eligibilityEffect of vaccination eligibility
Effect of vaccine receiptEffect of vaccine receipt
−9.1 (−16.7, −3.1)
−6.9 (−12.8, −1.0)
−34.7 (−63.0, −9.8)
−28.9 (−53.8, −3.9)
3.3 (−5.1, 12.0)
4.0 (−3.4, 11.3)
12.5 (−20.6, 45.4)
16.7 (−14.6, 47.9)
−13.9 (−26.3, −3.4)
−14.9 (−23.9, −5.8)
−52.3 (−97.9, −9.2)
−62.1 (−101.5, −22.7)
0.004
0.023
0.007
0.023
0.434
0.288
0.462
0.296
0.011
0.001
0.018
0.002
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−100 −50 0 50
Regression discontinuity
Difference−in−diff
erences
Women
All−cause mortality
Non−dementia deaths
Deaths due to dementia
Effect of vaccination eligibilityEffect of vaccination eligibility
Effect of vaccine receiptEffect of vaccine receipt
Effect of vaccination eligibilityEffect of vaccination eligibility
Effect of vaccine receiptEffect of vaccine receipt
Effect of vaccination eligibilityEffect of vaccination eligibility
Effect of vaccine receiptEffect of vaccine receipt
−1.3 (−9.4, 5.5)
−2.4 (−8.6, 3.8)
−4.1 (−29.7, 17.5)
−8.3 (−30.0, 13.3)
−2.7 (−12.0, 7.1)
−3.8 (−13.9, 6.3)
−9.2 (−41.4, 24.0)
−13.4 (−49.2, 22.4)
1.3 (−12.4, 13.0)
0.4 (−11.0, 11.8)
4.3 (−40.1, 41.6)
1.4 (−38.9, 41.7)
0.609
0.453
0.613
0.450
0.614
0.462
0.602
0.465
0.966
0.944
0.970
0.944
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−100 −50 0 50
Regression discontinuity
Difference−in−diff
erences
Men
Figure S8. The effect of HZ vaccination eligibility and receipt on deaths due to dementia, non-dementia deaths, and all-cause mortality
separately among women and men, related to Figure 5
Dots show the point estimate and horizontal bars the 95% CI. All outcomes were analyzed among a study cohort of patients who had received a diagnosis of
dementia prior to the start date of the HZ vaccination program. Non-dementia deaths were defined as deaths for which dementia was neither the underlying nor a
contributing cause of death in the death certificate.
Abbreviation is as follows: CI, confidence interval.
ll
OPEN ACCESS
Article
Other checks
Grace−period (months)
Ban
dwidth choice (as x−times the MSE−optimal bandwidth)
Accounting for staggered roll−outAccounting for staggered roll−out
Adjusting for baseline IHD diagnosisAdjusting for baseline IHD diagnosis
Quadratic fitQuadratic fit
00
22
44
0.50.5
0.750.75
11
1.251.25
1.51.5
1.751.75
2 2
−6.8 ( −13.1, −2.3)
−26.1 ( −50.3, −8.3)
−3.2 ( −6.0, −0.5)
−12.3 ( −22.7, −1.9)
−7.7 ( −14.5, −2.5)
−25.9 ( −47.5, −7.3)
−6.5 ( −12.5, −2.1)
−22.7 ( −42.8, −6.5)
−7.2 ( −13.6, −2.4)
−24.9 ( −46.6, −7.3)
−8.4 ( −15.7, −3.1)
−29.1 ( −54.1, −9.2)
−9.1 ( −17.5, −2.6)
−32.9 ( −63.5, −9.6)
−8.1 ( −15.5, −3.4)
−28.5 ( −53.8, −11.1)
−6.5 ( −12.5, −2.1)
−22.7 ( −42.8, −6.5)
−5.3 ( −10.6, −1.2)
−19.2 ( −37.7, −4.0)
−4.6 ( −9.7, −1.1)
−17.4 ( −36.4, −4.4)
−4.4 ( −9.1, −1.2)
−16.8 ( −35.2, −5.1)
−4.3 ( −8.6, −1.2)
−16.4 ( −33.3, −4.9)
0.005
0.006
0.022
0.020
0.006
0.008
0.006
0.008
0.005
0.007
0.003
0.006
0.008
0.008
0.002
0.003
0.006
0.008
0.014
0.015
0.014
0.013
0.010
0.009
0.010
0.008
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−80 −40 0
Effect of vaccination eligibility
Effect of vaccine receipt
Effect on all−cause mortality
Other checks
Grace−period (months)
Ban
dwidth choice (as x−times the MSE−optimal bandwidth)
Accounting for staggered roll−outAccounting for staggered roll−out
Adjusting for baseline IHD diagnosisAdjusting for baseline IHD diagnosis
Quadratic fitQuadratic fit
00
22
44
0.50.5
0.750.75
11
1.251.25
1.51.5
1.751.75
2 2
−8.5 ( −16.4, −2.3)
−34.8 ( −66.7, −7.6)
−8.1 ( −12.1, −4.0)
−33.4 ( −50.2, −16.6)
−9.2 ( −16.8, −2.3)
−34.8 ( −63.1, −6.8)
−9.1 ( −16.7, −3.1)
−34.7 ( −63.0, −9.8)
−11.8 ( −20.3, −5.5)
−44.4 ( −77.2, −17.3)
−10.9 ( −19.8, −4.2)
−41.2 ( −75.3, −12.7)
−12.8 ( −23.8, −5.2)
−48.4 ( −92.2, −17.2)
−10.9 ( −20.2, −4.8)
−40.9 ( −75.6, −15.2)
−9.1 ( −16.7, −3.1)
−34.7 ( −63.0, −9.8)
−7.9 ( −15.0, −2.7)
−31.5 ( −59.3, −9.4)
−7.5 ( −14.5, −3.1)
−31.0 ( −59.3, −12.3)
−7.4 ( −13.8, −3.3)
−30.8 ( −58.0, −13.5)
−6.9 ( −12.7, −2.7)
−29.0 ( −53.4, −11.4)
0.010
0.014
<0.001
<0.001
0.010
0.015
0.004
0.007
0.001
0.002
0.002
0.006
0.002
0.004
0.002
0.003
0.004
0.007
0.005
0.007
0.002
0.003
0.002
0.002
0.002
0.003
Effect size, 95% CI
(percentage points)
p
Effect size, 95% CI
(percentage points)
−125 −100 −75 −50 −25 0
Effect of vaccination eligibility
Effect of vaccine receipt
Effect on all−cause mortality among women
(legend on next page)
ll
OPEN ACCESS
Article
Figure S9. Robustness checks for the effect of HZ vaccination eligibility and receipt on all-cause mortality among patients living with de-
mentia at baseline, related to Figure 5
Baseline refers to the start date of the HZ vaccination program (i.e., September 1, 2013). Dots or triangles show the point estimate and horizontal bars the 95% CI.
With grace periods, we refer to time periods since the index date after which follow-up time is considered to begin to allow for the time needed for a full immune
response to develop after vaccine administration. As described in detail in the STAR Methods section, when accounting for the staggered roll-out of the program,
we adjusted the follow-up period to begin for each individual on the date on which they first became eligible for HZ vaccination (instead of starting the follow-up
period for all individuals on September 1, 2013). We added cohort fixed effects to these analyses to control for between-cohort differences in the date at which the
follow-up window started. That is, we defined one cohort fixed effect for ineligible individuals and the first catch-up cohort and included additional cohort fixed
effects for each group of patients who became eligible at the same time.
Abbreviations are as follows: CI, confidence interval; MSE, mean squared error; IHD, ischemic heart disease.
ll
OPEN ACCESS
Article
44.13
3.92
0.13
1.01
38.04
9.05
0.7
5.49
22.6
6.39
7.23
2.58
43.24
3.81
0.26
1.31
32.21
10.6
4.45
0.67
40.4
9.81
0.57
1.74
27.41
12.66
5.88
Start of eligibility: 2019−04−01
Birth cohort: [1941−09−02, 1942−09−02)
Start of eligibility: 2016−04−01
Birth cohort: [1937−09−02, 1938−09−02)
Start of eligibility: 2017−04−01
Birth cohort: [1938−09−02, 1940−09−02)
Start of eligibility: 2018−04−01
Birth cohort: [1940−09−02, 1941−09−02)
Start of eligibility: 2013−09−01
Birth cohort: [1933−09−02, 1934−09−02)
Start of eligibility: 2014−09−01
Birth cohort: [1934−09−02, 1936−09−02)
Start of eligibility: 2015−04−01
Birth cohort: [1936−09−02, 1937−09−02)
−6 0 1 2 8
−6 0 1 2 8 −6 0 1 2 8
0
20
40
60
0
20
40
60
0
20
40
60
Year since start of vaccination eligibility period
Received HZ vaccination (in % of the eligible birth cohort)
Among patients without cognitive impairment at baseline and residing in Wales at the start of eligibility
24.68
2.88
0.23
0.27
19.57
4.56
0.27
4.76
11.31
1.79
4.76
1.24
23.17
2.63
0.51
0.19
15.46
4.47
3.35
22.56
6.5
0.41
1.02
12.69
8.12
Start of eligibility: 2019−04−01
Birth cohort: [1941−09−02, 1942−09−02)
Start of eligibility: 2016−04−01
Birth cohort: [1937−09−02, 1938−09−02)
Start of eligibility: 2017−04−01
Birth cohort: [1938−09−02, 1940−09−02)
Start of eligibility: 2018−04−01
Birth cohort: [1940−09−02, 1941−09−02)
Start of eligibility: 2013−09−01
Birth cohort: [1933−09−02, 1934−09−02)
Start of eligibility: 2014−09−01
Birth cohort: [1934−09−02, 1936−09−02)
Start of eligibility: 2015−04−01
Birth cohort: [1936−09−02, 1937−09−02)
−6 0 1 2 8
−6 0 1 2 8 −6 0 1 2 8
0
20
40
60
0
20
40
60
0
20
40
60
Year since start of vaccination eligibility period
Received HZ vaccination (in % of the eligible birth cohort)
Among patients living with dementia at baseline and residing in Wales at the start of eligibility
Figure S10. Uptake of herpes zoster vaccination by birth cohort and year of eligibility, related to Figure 1
Baseline refers to the start date of the HZ vaccination program (i.e., September 1, 2013). The green bar corresponds to the respective first year of eligibility for a
particular cohort. Eligibility years 2 to 8 had to be aggregated to comply with SAIL data publication standards.
Abbreviation is as follows: HZ, herpes zoster.
ll
OPEN ACCESS
Article
Among patients without cognitive impairment at baseline Among patients living with dementia at baseline
1926 1927 1928 1929 1930 1931 1932 1933 1926 1927 1928 1929 1930 1931 1932 1933
−20
−10
0
10
Cohort
Difference (% points)
P<0.05
True
F
alse
Figure S11. Difference in the incidence of our primary outcomes between the pre- and post-September birth ‘seasons’’ for each yearly birth
cohort, related to STAR Methods section Evidence triangulation
Baseline refers to the start date of the HZ vaccination program (i.e., September 1, 2013). ‘Difference’’ refers to the difference between the pre- and post-
September birth seasons. The pre-September birth season was defined as the 6-month period from March 1 to August 31 of a given year and the post-September
birth season as the 6-month period from September 1 to February 28 of the succeeding year. The outcome was new diagnoses of MCI for the study cohort among
patients without cognitive impairment at baseline, and deaths due to dementia for the study cohort among patients living with dementia at baseline.
The 1932/1933-cohort served as the reference cohort. Statistically significant differences (indicated in red) for birth-year cohorts other than the 1933/1934 cohort
indicate that the assumption needed for an unbiased difference-in-differences analysis may not be met. The regression equations for this analysis are detailed in
the STAR Methods.
ll
OPEN ACCESS
Article

Discussion

Because neuroinflammation is thought to be central to how dementia starts and worsens, the authors suggest that viruses that infect the nervous system could potentially trigger or speed up dementia-related pathology. They point out that neurotropic herpesviruses are a major focus of this hypothesis because they can remain dormant in the nervous system for life, tend to reactivate more often as people age, and can sometimes cause serious brain inflammation like encephalitis. Interest has grown further due to experimental evidence that certain herpesviruses can promote Alzheimer’s-like changes, such as seeding β-amyloid in mice and increasing tau phosphorylation in human brain organoids. They also note that the broader idea of viral contributions to chronic neurologic disease has gained credibility from findings like Epstein–Barr virus playing a causal role in multiple sclerosis. > "To guide further research in this area and, ultimately, inform appropriate clinical care, it is critical to understand at which stage of the disease course of dementia HZ vaccination has its benefit. Our previous analyses in Wales and Australia have left this question unanswered. The aims of this study, therefore, were 2-fold: to determine the effect of HZ vaccination on (1) new diagnoses of mild cognitive impairment (MCI) among individuals without any record of cognitive impairment and (2) deaths due to dementia among individuals living with dementia. In the absence of more widespread testing for β-amyloid and tau pathology during the study period (2013–2022), these two aims represent the two opposite ends of the disease course of dementia (considering the limitations in ascertaining different disease stages in electronic health record data). Here, we report a large beneficial effect from live-attenuated HZ vaccination for both aims, suggesting that the vaccine appears to act across the entire clinical disease course of dementia." Natural experiments are situations where real-world events, policies, or rules assign people to different conditions in a way that’s plausibly “as if random,” letting researchers estimate causal effects without running a controlled trial. The idea has roots in early observational reasoning (like John Snow’s 1854 cholera work) and became more formal in the 20th century as economists and epidemiologists developed modern causal inference tools to treat policy cutoffs, lotteries, and shocks as sources of quasi-random variation. In practice, a natural experiment happens when an external change—say a birthdate-based eligibility rule, a sudden law change, or a draft lottery—creates comparable groups that differ mainly in exposure to the intervention. Researchers then analyze outcomes across those groups (often using methods like difference-in-differences, regression discontinuity, or instrumental variables) to infer what the intervention caused. > In conclusion, this study suggests that HZ vaccination slows or prevents disease progression across the entire disease course (as far as it can be feasibly ascertained from electronic health record data) of dementia. By taking advantage of the fact that the UK’s National Health Service assigned individuals who differed in their age by just a few weeks to being eligible or ineligible for HZ vaccination based on their date of birth, we were able to generate evidence that is more likely to be causal than those from more standard epidemiological analyses. Our finding that HZ vaccination had a beneficial effect on two different dementia-related outcomes in two different patient samples—and at two opposing ends of the disease course of dementia—thus provides promising evidence that HZ vaccination may prevent or slow the dementia disease process in a substantial proportion of individuals. This is a very interesting resullt: > "The effect of HZ vaccination—both on reducing new diagnoses of MCI and deaths due to dementia—was larger among women than men" This study asks whether shingles vaccination matters only for preventing dementia, or whether it also helps earlier (mild cognitive impairment, MCI) and later (after dementia diagnosis) stages of the disease course. The authors leverage a policy quirk in Wales: when the shingles vaccination program began on September 1, 2013, people whose 80th birthday fell just after that date were eligible for a year, while those whose 80th birthday fell just before were no longer eligible—creating a near-random eligibility cutoff between otherwise similar individuals. Using linked electronic health records and death certificate data with up to a 9-year follow-up, they apply a regression discontinuity design (with supporting difference-in-differences analyses) to estimate the causal impact of vaccine eligibility and then infer effects of actual vaccination by scaling for take-up. They find two main effects. First, shingles vaccine eligibility is associated with fewer new MCI diagnoses over 9 years (a 1.5 percentage-point reduction), and the implied effect of actually receiving the vaccine is a 3.1 percentage-point reduction. Second, among individuals already living with dementia at baseline, eligibility is associated with fewer deaths due to dementia over 9 years (an 8.5 percentage-point reduction; 29.5 percentage points when scaled to vaccine receipt), with effects appearing larger in women. The paper reports limited evidence that the results are driven by general “healthier patient” behavior or preventive-care uptake, and exploratory analyses suggest the benefits are not confined to a single dementia subtype. The authors interpret the findings as evidence that shingles vaccination may both delay early cognitive decline and slow later dementia progression, motivating further work to confirm mechanisms and generalizability.